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 Production of a functional protein requires coordination and regulation of 
many factors that control different cellular processes. One of these factors, Spt6, 
is a highly conserved nuclear protein that has roles in several facets of gene 
expression. Spt6 is best known for its ability to chaperone histones and modulate 
chromatin structure, but it also functions as a transcription elongation factor and 
in mRNA processing and export. Spt6 co-localizes with elongating RNA 
polymerase II (RNAPII) where it reassembles nucleosomes following RNAPII 
passage in order to repress aberrant transcription initiation. Furthermore, Spt6 
directly stimulates RNAPII elongation rates and coordinates co-transcriptional 
mRNA processing. Despite the wealth of functional data that implicate Spt6 in 
these processes, little is known about the mechanistic basis for these activities. 
In order to gain mechanistic understanding of Spt6 activities, the work presented 
in this thesis focused on biochemical, structural, and functional characterization 
of Spt6 interactions with other proteins. 
 These studies reveal the true Spt6 binding site on RNAPII, identify Tom1 
as a novel Spt6 binding partner, and demonstrate a specific interaction between 
Spt6 and histones H3-H4 that is competitive with DNA. The elucidation of the 
authentic Spt6 binding site on RNAPII has allowed us to develop tools to probe 
the mechanism of Spt6 recruitment to transcribed regions. Identification of Tom1
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 as a phosphorylated Spt6 binding partner provides a physical link to potential 
Spt6 functions such as mRNA export, cell cycle regulation, and regulation of 
histone levels. Characterization of the interaction with H3-H4 brings us closer to 
a mechanistic understanding of the histone chaperone activity of Spt6. Overall, 
the data presented in this work advance our knowledge of the interactions that 
regulate Spt6 function and will aid future studies to further dissect the 
mechanistic basis for Spt6 roles in gene expression.  
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 The central dogma of biology distills gene expression into its two most 
basic steps: transcription and translation. Transcription is the process by which 
the information encoded in a gene is read and copied into a messenger RNA 
(mRNA). Translation is the process by which the information in an mRNA is used 
to synthesize a functional protein from amino acids. In reality, gene expression is 
a complex, multistep process with multiple layers of regulation. Consequently, 
many factors exist to facilitate, coordinate, and regulate the many facets of gene 
expression. One of these factors, Spt6, functions in several key regulatory 
processes including modulation of chromatin structure and DNA accessibility, 
transcription initiation and elongation, and mRNA processing and export. This 
thesis focuses on Spt6 interactions and how they contribute to different facets of 
gene expression.   
 
Chromatin Structure and Dynamics 
 
 Every cell in the human body contains nearly 2 meters of DNA that are 
condensed into a nucleus with a diameter of about 10 µM (Marino-Ramirez et al., 
2005). This remarkable packaging feat is accomplished by compacting DNA into 
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a nucleoprotein complex called chromatin. The most basic unit of chromatin is 
the nucleosome, which consists of DNA wrapped around core histone proteins 
(Luger et al., 1997). Nucleosomes facilitate assembly of higher order chromatin 
structures that have been divided into three hierarchical tiers of compaction 
(Figure 1-1) (Woodcock and Dimitrov, 2001). The first tier consists of 
nucleosomal arrays that are ~11 nm wide and resemble ‘beads on a string.’ 
Nucleosomal arrays are further compacted, with the aid of additional proteins 
such as histone H1, into the next tier of chromatin structure known as the 30 nm 
fiber (Thomas, 1999). The structure of the 30 nm fiber has been controversial 
(Dorigo et al., 2004; Finch and Klug, 1976; Robinson et al., 2006; Williams et al., 
1986), but a recent cryo-EM reconstruction provides strong evidence supporting 
a two-start helix (Song et al., 2014). The third tier of chromatin structure consists 
of 300 and 700 nm fibers that are formed by inter-fiber interactions (Kan et al., 
2007; Li and Reinberg, 2011).  
 While assembling DNA into chromatin is an effective packaging strategy, it 
also restricts access for DNA-templated processes including replication, repair, 
and transcription. As a result, chromatin state is intimately tied to biological 
processes. Therefore, packaging and unpacking of each tier of chromatin 
structure is dynamic and highly regulated to allow precise spatial and temporal 
access to DNA (Luger and Hansen, 2005). The dynamic assembly and 
disassembly of chromatin is made possible by the unique structure of the 





Figure 1.1. Organization of the genome into chromatin.  





 The composition and general shape of the nucleosome has been known 
for decades (Kornberg, 1977), but high-resolution structures remained elusive 
until the mid-1990s. In 1997, a 2.8 angstrom structure revealed the first atomic 
view of the nucleosome core particle (NCP) (Luger et al., 1997). The NCP 
consists of a histone octamer composed of two copies of each of the four core 
histones H2A, H2B, H3, and H4 that are wrapped by ~147 base pairs of DNA in a 
left-handed superhelix. Within the octamer, H2A dimerizes with H2B, and H3 
dimerizes with H4, for a total of four histone pairs (Figure 1.2). The H3-H4 dimers 
further assemble into an H3-H4 heterotetramer [(H3-H4)2] that is flanked by the 
H2A-H2B dimers to create a left-handed superhelix that templates the DNA.  
 The four core histones share a structurally similar helix-turn-helix-turn-
helix motif that has been named the histone fold (Arents et al., 1991; Luger et al., 
1997). The histone fold facilitates heterodimeric interactions between dimer pairs 
in what is known as the “handshake motif.” The (H3-H4)2 tetramer is formed 
through a four-helix bundle between H3 and H3’, and the H2A-H2B dimers 
interact with (H3-H4)2 through analogous 4-helix bundles between H2B and H4. 
In total, the histone octamer contacts 121 base pairs of DNA primarily through 
the phosphodiester backbone. The extensive protein-protein and protein-DNA 
interactions explain the stable structure of the nucleosome.  
 Disordered tails extend from the ordered histone folds and do not 
contribute to the structure of the NCP. The tails are rich in lysine, arginine, and 




Figure 1.2: Structure of the nucleosome.  
A) Orthogonal views of the nucleosome core particle represented in ribbons. 
H2A: yellow; H2B: red; H3: blue; H4: green; DNA: grey.  
B and C) View of the H3-H4 tetramer and H2A-H2B dimer removed from the 
nucleosome. Histone tails are indicated.   
Figure created using UCSF Chimera (Pettersen et al., 2004) using PDB ID: 1kx5 
(Davey et al., 2002). 
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phosphate, ubiquitin, and other moieties to regulate chromatin compaction and 
recruitment of specific factors (Bannister and Kouzarides, 2011; Rothbart and 
Strahl, 2014). The histone tails and their modification states contribute to the 
assembly of higher order chromatin structures, with the H4 tail having the most 
pronounced effect (McBryant et al., 2009; Shogren-Knaak et al., 2006; Wang and 
Hayes, 2008). Generally speaking, histone posttranslational modifications 
(PTMs) regulate chromatin state either by recruiting effector proteins or by 
directly affecting nucleosome and chromatin structure (Li and Reinberg, 2011; 
Taverna et al., 2007). Effector proteins are recruited to chromatin through reader 
domains that recognize specific histone modifications in order to facilitate the 
coordinated recruitment of machinery that acts on chromatin. Modifications that 
alter chromatin structure directly tend to weaken inter- and intra-nucleosomal 
contacts by neutralizing positive charges on the highly basic histones (Shogren-
Knaak et al., 2006). Because histone modifications have profound effects on 
chromatin structure, the histone modification state is intimately tied to regulation 
of DNA-templated processes.  
 In some cases, the canonical core histones are replaced by histone 
variants that resemble their canonical counterparts but differ in primary 
sequence. Sequence variations range from several amino acids to more dramatic 
changes such as the introduction of new domains (Mattiroli et al., 2015; Maze et 
al., 2014). H2A variants are the most diverse family of core histones while H2B 
and H3 variants are more similar to their counterparts. Variant histones alter the 




 Like higher order chromatin structures, nucleosomes pose barriers to 
DNA-templated processes. Consequently, nucleosome position and stability are 
linked to biological function. Transcription is one of several processes that 





 Transcription is the process by which genetic information stored as DNA is 
copied as a molecule of RNA. In eukaryotes, the three enzyme complexes that 
catalyze RNA synthesis are called RNA polymerase (RNAP) I, II, and III. Each 
polymerase transcribes a different class of genes. RNAPI is responsible for 
transcription of ribosomal RNAs (rRNA), which are used in ribosomal assembly 
and account for approximately 50% of cellular transcription. RNAPII transcribes 
protein-coding genes to produce mRNA as well as DNA encoding small nuclear 
RNA (snRNA) and micro RNA (miRNA). mRNA is used as the template for 
protein synthesis whereas snRNA and miRNA have roles in splicing and post-
transcriptional repression, respectively. RNAPIII transcribes small, structured 
RNAs such as 5S rRNA, tRNA, and spliceosomal U6 snRNAs that are important 
for ribosome biogenesis, protein synthesis, and splicing, respectively. Of the 






RNAPII Structure and the CTD 
 RNAPII is a 12 subunit complex consisting of proteins Rpb1-Rpb12 
(Figure 1.3A) (Cramer et al., 2000). Ten of the subunits form the catalytic core 
while the Rpb4 and Rpb7 subunits form a heterodimer that can dissociate from 
the enzyme (Edwards et al., 1991; Mosley et al., 2013). The largest subunit, 
Rpb1, contains an unstructured C-terminal domain (CTD) that consists of 
heptapeptide repeats of the consensus sequence Y1S2P3T4S5P6S7. The CTD is 
subject to multiple reversible modifications including peptidyl-prolyl isomerization, 
glycosylation, and phosphorylation that create a dynamic binding surface that 
recruits chromatin regulators and mRNA processing factors. The modification 
state of the CTD is coupled to the transcription cycle, facilitating co-
transcriptional coordination of chromatin state and mRNA processing (Figure 
1.3B).  
 The best characterized of the CTD modifications are tyrosine, serine, and 
threonine phosphorylation. Recent mass spectrometry experiments determined 
that S2 and S5 phosphorylation are the most abundant modifications, consistent 
with their importance in coordinating the stages of the transcription cycle as well 
as co-transcriptional mRNA processing (Schuller et al., 2016; Suh et al., 2016). 
Chromatin immunoprecipitation (ChIP) experiments using antibodies that 
recognize specific phosphorylation states of the CTD revealed that S5 
phosphorylation is most abundant in the 5’ region of genes whereas S2 
phosphorylation is most abundant in the 3’ region (Hintermair et al., 2012; Mayer 




Figure 1.3: Transcription by RNA polymerase II.  
A) Model of 12 subunit RNAPII with the Rpb1 linker and CTD. The core enzyme 
(PDB ID: 1Y1W) (Kettenberger et al., 2004) is shown as a surface representation 
with Rpb1 colored red and DNA colored yellow and cyan. The Rpb4/7 
heterodimer is highlighted. The Rpb1 linker and CTD are represented by solid 
and dashed lines, respectively. Figure created using UCSF Chimera (Pettersen 
et al., 2004).  
B) Overview of S2 and S5 phosphorylation of RNAPII CTD during the 
transcription cycle highlighting coordination of mRNA processing. 
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 mRNA capping enzyme and termination factors, respectively. 
 The Rpb1 CTD is tethered to the RNAPII core through a flexible ~80 
residue linker. The first 10 residues of the linker contact the Rpb4/7 heterodimer 
and are ordered in the Saccharomyces cerevisiae RNAPII crystal structures 
(Armache et al., 2005). In Schizosaccharomyces pombe, an additional 47 
residues of the linker are ordered due to additional contacts with Rpb4/7 (Spahr 
et al., 2009). Consequently, it has been suggested that the linker may influence 
transcription by stabilizing Rpb4/7 association with the core. While the CTD can 
support viability when fused to other RNAPII subunits, the linker is only functional 
when contiguous with Rpb1 (Suh et al., 2013). In Chapter 3 of this dissertation, I 
present evidence that a function of the Rpb1 linker is to bind Spt6. 
 
Initiation 
 Transcription by RNAPII occurs in three phases: initiation, elongation, and 
termination. During the initiation phase, a pre-initiation complex (PIC) is 
assembled from the general transcription factors (GTFs) and RNAPII (Kornberg, 
2007). The GTFs include TFIIB, -D, -E, -F, and –H and are necessary for 
promoter recognition and initiation of transcription. TFIIH contains multiple 
subunits with catalytic activities including a kinase module that phosphorylates S5 
of the RNAPII CTD (Akhtar et al., 2009). The exact architecture of the PIC is 
controversial, as two conflicting cryo-EM structures have been published from 
different groups (He et al., 2013; Murakami et al., 2013).  
 RNAPII that enters the PIC has an unphosphorylated CTD, which is a 
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binding surface for the multiprotein Mediator complex (Myers et al., 1998). 
Mediator stabilizes the PIC, communicates signals from transcription factors to 
RNAPII, and stimulates kinase activity of TFIIH (Sogaard and Svejstrup, 2007). 
Phosphorylation of S5 of the CTD by TFIIH recruits the mRNA capping enzyme 




 Transcription elongation is the processive addition of nucleotides to the 
nascent RNA chain. The elongation phase is characterized by a hyper-
phosphorylated CTD and association of transcription elongation and mRNA 
processing factors. The mRNA capping enzyme is recruited to RNAPII through 
direct interactions with the S5 phosphorylated CTD (Ho and Shuman, 1999) and 
catalyzes addition of a 5’ cap shortly after the nascent mRNA reaches the 
RNAPII surface (Rasmussen and Lis, 1993). The 5’ cap consists of a guanine 
nucleotide connected to the 5’ end of a transcript through a 5’ to 5’ triphosphate 
bond. The cap stabilizes the mRNA and protects against exonuclease digestion 
(Shuman, 2001).  
 Following mRNA capping, the CTD phosphorylation state shifts from S5 
phosphorylation to S2 phosphorylation (Mayer et al., 2010). This transition is 
mediated by activities of the Ssu72 phosphatase that dephosphorylates S5 
(Krishnamurthy et al., 2004) and the cyclin-dependent kinases Ctk1 and Bur1 
that phosphorylate S2 (Bowman and Kelly, 2014). Transcription elongation 
factors are recruited through direct interactions with the RNAPII core enzyme and 
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the S2 phosphorylated CTD. Elongation factors including Spt4/5, Polymerase 
Associated Factor 1 complex (Paf1C), FACT, and Spt6 enhance processivity by 
directly acting on RNAPII and/or influencing chromatin structure to allow RNAPII 
passage (Endoh et al., 2004; Hartzog et al., 1998; Kim et al., 2010; Orphanides 
et al., 1998).  
 During the elongation phase, a large ribonucleoprotein complex called the 
spliceosome catalyzes co-transcriptional splicing of the nascent RNA (Ardehali 
and Lis, 2009; Brugiolo et al., 2013; Osheim et al., 1985). Splicing is the removal 
of introns from the primary transcript, leaving only the protein coding sequence. 
The phosphorylated RNAPII CTD interacts directly with several splicing factors 
and is necessary for spliceosome assembly and proper splicing (Emili et al., 
2002; Hirose et al., 1999; Morris and Greenleaf, 2000). Therefore, CTD 




 The end of transcription elongation is signaled by passage through the 
poly(A) site, which triggers transcript cleavage and is a prerequisite for 
termination (Connelly and Manley, 1988; Logan et al., 1987). Termination occurs 
anywhere from several bases to several kilobases downstream from the poly(A) 
site (Hagenbuchle et al., 1984). Coincident with termination, the CTD is 
dephosphorylated, allowing recycling of RNAPII for subsequent rounds of 
initiation and elongation (Cho et al., 1999; Lian et al., 2008).  
 Two models, the allosteric model and the torpedo model, have been 
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proposed to describe how RNAPII is released from DNA. According to the 
allosteric model, transcription of the poly (A) signal causes conformational 
changes in the polymerase that destabilize the interaction with DNA, leading to 
decreased processivity followed by disassembly (Logan et al., 1987). In the 
torpedo model, the 5’ phosphate on the cleaved RNA recruits an exonuclease 
that degrades the RNA and stimulates DNA release upon catching up to the 
polymerase (Connelly and Manley, 1988). Because both models are supported 
by data, the current view is that the allosteric and the torpedo mechanisms both 
contribute to transcription termination (Richard and Manley, 2009).   
 Transcription of the poly(A) site also signals cleavage and polyadenylation 
of the transcript. Polyadenylation is the addition of multiple adenosine 
monophosphates to the 3’ end of an mRNA and is important for nuclear export, 
translation, and stability of the mRNA (Colgan and Manley, 1997). Like mRNA 
capping and splicing, cleavage and polyadenylation are coupled to the 
transcription cycle via the RNAPII CTD (de Almeida and Carmo-Fonseca, 2008). 
The S2 phosphorylated CTD directly interacts with several components of the 
cleavage-polyadenylation machinery in order to coordinate recruitment with 
termination (Lunde et al., 2010; Meinhart and Cramer, 2004). This helps ensure 
that only completely synthesized mRNAs are processed and become export 
competent. 
 
Transcription Through Nucleosomes 
 
 Nucleosomes pose a physical barrier to transcription initiation and 
elongation. Assembly of the PIC requires chromatin to be in an open 
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conformation. Consequently, many promoters are void of nucleosomes to allow 
transcription factors access to DNA binding site (Bernstein et al., 2004; Lee et al., 
2004; Sekinger et al., 2005). Alternatively, some genes, such as PHO5 and 
PHO8, use strategically placed nucleosomes in the promoter to repress 
transcription until the nucleosomes are removed or repositioned (Adkins and 
Tyler, 2006). Nucleosomes in the coding region also impede transcription by 
preventing RNAPII passage during elongation (Lorch et al., 1992). Because 
nucleosomes have such profound effects on transcriptional output, they present 
an important mechanism for transcriptional regulation. Therefore, both initiation 
and elongation require remodeling, repositioning, or removal of nucleosomes to 
allow assembly of the PIC or passage of RNAPII. In addition, nucleosomes must 
be reassembled and repositioned following RNAPII passage in order to restore 
the default repressive chromatin state. Two classes of proteins, chromatin 




 Chromatin remodelers hydrolyze ATP to slide, eject, assemble, or 
restructure nucleosomes to alter their position, occupancy, and composition. 
These activities control the packaging and unpackaging of chromatin to regulate 
DNA access for chromosomal processes. All remodelers share a similar ATPase 
domain, but unique flanking domains and associated subunits provide 
specialization (Clapier and Cairns, 2009). Remodelers are divided into four 
distinct families that are specialized for different functions and biological contexts. 
Domains that recognize specific histone modifications contribute to specialization 
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by linking remodeler activity to posttranslational modification states (Bannister 
and Kouzarides, 2011; Clapier and Cairns, 2009). The influence of remodelers 
on nucleosomes and chromatin not only influences transcription, but also has 
implications for chromatin assembly, DNA replication, and DNA repair and 




 Histone chaperones are a structurally diverse class of proteins that use 
binding energy to assemble or disassemble nucleosomes in order to regulate 
DNA accessibility during DNA-templated processes (De Koning et al., 2007; 
Laskey et al., 1978). Because histones are highly basic, non-nucleosomal 
histones are prone to aberrant interactions with DNA and acidic proteins. These 
interactions lead to aggregation and cell toxicity (Meeks-Wagner and Hartwell, 
1986). To prevent nonproductive histone-DNA interactions, histone chaperones 
have highly acidic regions that interact with the basic histone surface to 
neutralize the charges. The coordinated activities of multiple histone chaperones 
facilitates the stepwise assembly and disassembly of nucleosomes (Das et al., 
2010).  
 Histone chaperones are often classified by their specificity for different 
histones (Gurard-Levin et al., 2014). Typically, chaperones bind either H2A-H2B 
or H3-H4, although Spt6 and FACT have been shown to bind both (Bortvin and 
Winston, 1996; Formosa, 2012; Kemble et al., 2013; McCullough et al., 2015). In 
addition, some chaperones have specificity for histones variants (Mattiroli et al., 
2015). Histone chaperones use a variety of structural motifs to interact with 
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histones, but structural studies have revealed common themes (Elsasser, 2013; 
Hondele and Ladurner, 2011; Kemble et al., 2015). Notably, chaperones tend to 
bind histone surfaces that are buried in a fully assembled nucleosome. 
Therefore, it appears that histone chaperones ensure ordered nucleosome 
assembly and disassembly by competing with histone-DNA and histone-histone 
contacts to stabilize assembly intermediates (Das et al., 2010; Hondele and 
Ladurner, 2011). 
 Chaperones function in many biological processes including DNA 
replication, transcription, repair, and heterochromatic silencing (Gurard-Levin et 
al., 2014). During replication and transcription, nucleosomes must be 
disassembled in front of a polymerase and reassembled behind. The similar 
topology of these processes allows some chaperones to function in both 
replication and transcription. Other chaperones, such as Spt6, are specific to 




 Spt6 was initially identified by Fred Winston in a genetic screen for 
suppressors of a Ty element insertion at the 5’ end of the HIS4 gene (Winston et 
al., 1984). Ty insertion at the HIS4 gene causes transcriptional repression and 
the inability to grow on media lacking histidine. Suppressors of Ty insertions 
relieve transcriptional repression of HIS4, allowing growth on media lacking 
histidine. This phenomenon is designated the Spt- phenotype, and is shared by 
all members of the Spt gene family. Since nucleosomes are essential for global 
transcriptional repression, the Spt- phenotype often indicates loss of chromatin 
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integrity (Hainer et al., 2011; Kaplan et al., 2003). Therefore, it is unsurprising 
that Spt6 functions in global transcriptional regulation (Clark-Adams and Winston, 
1987; Denis and Malvar, 1990; Neigeborn et al., 1987; Swanson and Winston, 
1992). 
 Since Spt6 was identified, it has been implicated in a variety of biological 
processes throughout eukaryotes. Spt6 is important for embryogenesis in 
Zebrafish (Keegan et al., 2002; Kok et al., 2007), multiple stages of development 
in Drosophila (Ardehali et al., 2009), gut morphogenesis in C. elegans (Nishiwaki 
et al., 1993), and HIV transcriptional regulation in mammals (Vanti et al., 2009; 
Yoh et al., 2007). The broad importance of Spt6 is a consequence of diverse 
roles in gene expression including chaperoning histones, transcription 
elongation, and mRNA processing and export (Figure 1.4).  
 
Spt6 Is a Histone Chaperone 
 
 The Spt- phenotype caused by spt6 mutants is attributed to the 
requirement of Spt6 for maintaining repressive chromatin. The first evidence that 
Spt6 regulates chromatin state came from genetics. Mutations in SPT6 suppress 
mutations in the Swi/Snf chromatin remodeling complex similar to deletion of one 
copy of the H2A-H2B gene pairs (Bortvin and Winston, 1996; Hirschhorn et al., 
1992; Swanson and Winston, 1992). Spt6 is now known to directly bind H2A-H2B 
and H3-H4 and to promote nucleosome assembly in vitro (Bortvin and Winston, 
1996; McCullough et al., 2015). Consistent with this, spt6 mutations alter 
chromatin structure in the regulatory region of several genes, leading to spurious 




Figure 1-4: Overview of Spt6 roles in gene expression.  
Spt6 is implicated in three distinct functions in gene expression.  It is a 
transcription elongation factor that stimulates RNAPII elongation rates on naked 
DNA in vitro. It is also a histone chaperone that reassembles nucleosomes in the 
wake of elongating RNAII. It is also implicated in mRNA processing and export. 
Figure created using UCSF Chimera (Pettersen et al., 2004). 
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 Hainer et al., 2011). The role of Spt6 in maintaining repressive chromatin 
extends beyond promoters to coding regions. Impaired Spt6 function results in 
decreased nucleosome occupancy throughout transcribed regions, leading to 
aberrant transcription initiation from cryptic promoters (Adkins and Tyler, 2006; 
DeGennaro et al., 2013; Ivanovska et al., 2011; Kaplan et al., 2003). Therefore, 
Spt6 appears to maintain repressive chromatin by reassembling nucleosomes in 
both promoters and in coding regions following RNAPII passage. 
 
Spt6 Is a Transcription Elongation Factor 
 While the histone chaperone function of Spt6 undoubtedly impacts 
transcription elongation, Spt6 also directly affects the transcription machinery. In 
vivo, Spt6 stimulates elongation rates even when chromatin is in a permissive 
state (Ardehali et al., 2009). Furthermore, Spt6 enhances RNAPII elongation 
rates in vitro on DNA lacking nucleosomes (Endoh et al., 2004; Yoh et al., 2007). 
The role of Spt6 in transcription elongation is also supported by genetic 
evidence. spt6 mutants display phenotypes associated with impaired 
transcription elongation such as sensitivity to 6-Azauracil (6-AU) and synthetic 
growth defects with transcription elongation factors (Hartzog et al., 1998; Sun et 
al., 2010; Winston et al., 1984). Consistent with roles for Spt6 in transcription 
elongation and co-transcriptional nucleosome assembly, Spt6 physically 
associates with elongating RNAPII and localizes to genes with a pattern similar 
to RNAPII (Andrulis et al., 2000; Kaplan et al., 2000; Kim et al., 2004; Mayer et 




Spt6 Is Involved in mRNA Processing and Export 
 In addition to nucleosome assembly and transcription elongation, Spt6 
also functions in mRNA processing and export. In yeast, spt6 mutants are 
defective in transcription termination, 3’ processing, and mRNA export (Bucheli 
and Buratowski, 2005; Estruch et al., 2009; Kaplan et al., 2005). Consistent with 
these observations, Spt6 genetically interacts with the mRNA export factors 
Mex67 and Yra1 (Burckin et al., 2005; Estruch et al., 2009). In mammals, Spt6 is 
required for nuclear export of mRNA as well as proper splicing of an HIV 
transcript (Yoh et al., 2007). Furthermore, Spt6 physically associates with the 
RNA processing exosome in Drosophila (Andrulis et al., 2002). It is unclear how 
Spt6 functions in mRNA processing and export, but it likely facilitates co-
transcriptional recruitment of mRNA processing and export factors such as Spn1 




 Spt6 comprises 1,451 residues that can be divided into three structural 
regions: a disordered N-terminal region, a structured core, and a C-terminal 
tandem Src homology 2 (tSH2) domain (Close et al., 2011). The disordered N-
terminal region comprises ~300 residues and is highly acidic, which is a common 
feature of histone chaperones. Residues 239-268 in this region interact with 
Spn1 and are necessary for binding nucleosomes (Diebold et al., 2010a; 
McDonald et al., 2010). Interestingly, these interactions are competitive, 
suggesting a switch mechanism in which Spn1 regulates Spt6 interaction with 
nucleosomes (McDonald et al., 2010). Consistent with this model, mutations in 
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histones H2A-H2B suppress temperature sensitivity caused by mutations in the 
Spt6-Spn1 interface (McCullough et al., 2015). While it is clear that the Spt6 N-
terminus is required for chaperoning histones, the mechanistic basis of this 
activity is not understood. In order to understand how Spt6 functions as a 
chaperone, it is necessary to characterize how Spt6 interacts with the different 
components of the nucleosome. In Chapter 5 of this dissertation, I present 
evidence that the Spt6-Spn1 binding region is sufficient for binding histones H3-
H4 and that this interaction is competitive with DNA.  
 The core of Spt6 contains multiple domains that are structurally similar to 
protein binding and DNA binding domains and has overall similarity to the 
prokaryotic transcription factor Tex (Close et al., 2011; Johnson et al., 2008). The 
Spt6 core structure is discussed in depth in Chapter 2. Briefly, recognizable 
structural motifs in the Spt6 core include a helix-turn-helix domain, a catalytically 
inactive YqgF domain, a helix-hairpin-helix domain, a death-like domain, and an 
S1 domain. The Spt6 core is capable of binding DNA in vitro; however, it is 
unclear if this interaction takes place in vivo (Close et al., 2011). Despite 
structural knowledge of the Spt6 core, the biological function is unclear. 
Structural similarity to Tex suggests an activity that is conserved among 
prokaryotes and eukaryotes, such as transcription on nucleosome-free DNA. 
 The C-terminus of Spt6 adopts a novel tSH2 domain that comprises the 
only recognizable SH2 domains in yeast (Close et al., 2011; Diebold et al., 
2010b; Sun et al., 2010). Spt6 tSH2 consists of two SH2 domains stacked rigidly 
on top of one another. The N-terminal SH2 domain (nSH2) retains the primary 
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determinants of phosphotyrosine binding, including an invariant arginine (R1282) 
that is essential for phosphotyrosine binding in canonical SH2 domains. The C-
terminal SH2 domain (cSH2), on the other hand, appears to be cryptic because 
residues critical for phosphotyrosine binding in canonical SH2 domains are 
substituted by amino acids with different chemical properties. The Spt6 tSH2 
domain is important for Spt6 function and is the main focus of Chapters 3 and 4 
of this dissertation.  
 
Spt6 tSH2 Domain 
 
 The tSH2 domain functions in most Spt6 activities including repressive 
chromatin maintenance, transcription elongation and termination, and mRNA 
processing and export. Deletion of the tSH2 domain in yeast causes slow growth, 
the Spt- phenotype, and phenotypes attributed to defects in transcription 
elongation (Diebold et al., 2010b; Hartzog et al., 1998; McCullough et al., 2015; 
Sun et al., 2010). In mammals, the tSH2 domain is implicated in class switch 
recombination, mRNA processing and export, and transcription elongation 
(Begum et al., 2012; Endoh et al., 2004; Okazaki et al., 2011; Yoh et al., 2007). 
Furthermore, the tSH2 domain is required for maximum Spt6 occupancy 
throughout transcribed genes (Burugula et al., 2014; Mayer et al., 2010).  
 The leading model for Spt6 tSH2 function is that it recruits Spt6 to RNAPII 
through direct interactions with the hyperphosphorylated CTD. This model 
originated from work in the Jones laboratory that showed direct binding between 
Spt6 tSH2 and purified, hyperphosphorylated RNAPII (Yoh et al., 2007). The 
interaction was recapitulated by purified GST-CTD that was phosphorylated in 
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vitro by the CTD kinase P-TEFb (Yoh et al., 2008). Prompted by these 
observations, we used fluorescence anisotropy to quantify binding between Spt6 
tSH2 and CTD-derived peptides with different phosphorylation states (Close et 
al., 2011). The measured dissociation constants (KD) for peptides with a single 
phosphorylated residue per repeat ranged from 110 to 250 µM. A peptide that 
was phosphorylated on both S2 and S5 of the CTD repeats had an affinity of 23 
µM, but this peptide may be more prone to nonspecific interactions due to the 
additional negative charges from the extra phosphates. Regardless, these 
affinities are much weaker than expected for SH2 domains binding to 
phosphorylated peptides, which typically bind with a KD between 0.2 and 1 µM 
(Machida and Mayer, 2005). In addition, mutating Spt6 residues that are critical 
for phosphotyrosine binding in canonical SH2 domains decreased affinity by only 
4 fold. These observations are consistent with data from other groups who used 
fluorescence anisotropy, pull-downs, and NMR to characterize Spt6 tSH2 binding 
to phosphorylated CTD-derived peptides (Diebold et al., 2010b; Liu et al., 2011; 
Mayer et al., 2012; Sun et al., 2010). One group did observe affinities of ~1 µM 
using fluorescence anisotropy, but the tighter affinity is likely due to abnormally 
low salt concentrations (10 mM NaCl) used in their assays (Mayer et al., 2012; 
Sun et al., 2010). Interestingly two of the studies raised the possibility of an 
additional phosphate-binding pocket on the back side of the non-canonical cSH2 
domain. This pocket is lined with positively charged residues including a lysine 
that has been conserved throughout evolution. The residue displays a shift in an 
NMR chemical shift perturbation experiment (Liu et al., 2011), and mutating it 
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caused a modest reduction in affinity (~2.4 fold) for a CTD-derived 
phosphorylated peptide (Sun et al., 2010). Collectively, the data from these 
studies hint at the presence of a non-canonical phosphate-binding pocket and 
suggest that the phosphorylated CTD may not be the biological binding partner of 
Spt6 tSH2. However, the field has largely accepted the model that Spt6 tSH2 
binds the RNAPII CTD. In Chapters 3 and 4 of this dissertation, I present 
evidence that the authentic Spt6 tSH2 binding partners are the RNAPII linker and 




 Tom1 is a 375 kDa E3 ubiquitin ligase with a C-terminal HECT domain 
and is homologous to mammalian Huwe1 (also called Mule, Lasu, Ureb1, Arf-
BP1, HectH9, E3Histone, Ptr1, Upl1, and Eel1). In yeast, deletion of Tom1 causes 
severe temperature sensitivity, nuclear accumulation of mRNA, and defects in 
nuclear division (Utsugi et al., 1999; Utsugi et al., 1995). In humans, mutations in 
the gene encoding Huwe1 are associated with cancer and intellectual disability 
(Froyen et al., 2012; Froyen et al., 2008; Inoue et al., 2013; Isrie et al., 2013; Liu 
et al., 2012; Nava et al., 2012; Zhao et al., 2009). The importance of Tom1 can 
be attributed to its roles in mRNA export, degradation of excess histones, 
transcription, and cell cycle regulation (Duncan et al., 2000; Iglesias et al., 2010; 
Kim and Koepp, 2012; Kim et al., 2012; Liu et al., 2005; Saleh et al., 1998; Singh 
et al., 2009; Utsugi et al., 1999). The role of Tom1 in mRNA export has been 
ascribed to ubiquitylation of the mRNA export adaptor Yra1 in order to facilitate 
its removal from mRNA ribonucleoprotein (mRNP) complexes prior to nuclear 
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export (Iglesias et al., 2010). Tom1 has also been reported to ubiquitylate 
histones, marking them for proteasomal degradation (Liu et al., 2005; Singh et 
al., 2009). As accumulation of excess non-nucleosomal histones is toxic to the 
cell, degradation via the ubiquitin proteasome system is an important mechanism 
for regulating free histone levels (Gunjan and Verreault, 2003; Meeks-Wagner 
and Hartwell, 1986). It is unclear how Tom1 functions in transcription, but it may 
involve ubiquitylation of components of the transcription coactivator complex 
SAGA (Saleh et al., 1998). Tom1 also controls degradation of Dia2 and Cdc6 
during the G1 phase of the cell cycle, linking Tom1 to cell cycle regulation (Kim 
and Koepp, 2012; Kim et al., 2012). Despite some functional overlap between 
Spt6 and Tom1, it is unclear how a direct interaction between the proteins 
contributes to cellular physiology. The biochemistry presented in Chapter 4 has 
produced tools that can now be used to dissect the biological importance of this 
interaction. 
 
Goals of This Dissertation 
 
 Spt6 is conserved throughout eukaryotes, is essential for viability in S. 
cerevisiae, and has several roles in gene expression including transcription 
elongation, chaperoning histones, and mRNA processing and export. The 
importance of Spt6 in these processes is well documented, but the mechanistic 
details are unclear. The goal of this dissertation is to characterize Spt6 
interactions with other proteins in order to understand how they relate to Spt6 
function. The primary objectives were to identify biologically relevant binding 
partners for the Spt6 tSH2 domain and characterize the interaction between Spt6 
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and histones. The biochemical and structural data presented demonstrate that 
Spt6 tSH2 directly binds RNAPII and Tom1 and that the Spt6-Spn1 binding 
region interacts with histones H3-H4. The data and assays presented lay the 
foundation for future studies to probe the regulation and biological significance of 
these interactions. 
Outline of Chapters 
 
Chapter 2: Crystal Structure of the S. cerevisiae Spt6 Core  
and C-terminal Tandem SH2 Domain 
 The work discussed in Chapter 2 was originally published in the May 13, 
2011 issue of Journal of Molecular Biology and is reprinted here in the published 
format. The focus of this work was to characterize the Spt6 structure, DNA 
binding, and phosphorylated RNAPII CTD binding. Sean Johnson and Devin 
Close solved the structure of the Spt6 core, and Devin solved the structure of 
Spt6 tSH2. Devin and Seth McDonald performed the DNA binding assays. I 
performed the bulk of the fluorescence anisotropy assays characterizing tSH2 
domain binding to phosphorylated CTD-derived peptides. These assays provided 
the motivation to look for other binding partners as described in Chapters 3 and 
4.  
 
Chapter 3: Mechanism of Phosphorylation Dependent  
Binding Between Spt6 and RNAPII 
 Work in this chapter identifies the authentic Spt6 tSH2 binding site on 
RNAPII. We show that the Rpb1 linker, but not the CTD, is necessary for Spt6 
tSH2 binding. Binding is enhanced by phosphorylation of a highly conserved 
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serine in the linker. A crystal structure of the Spt6 tSH2-Rpb1 linker complex 
reveals a novel phosphate-binding pocket that coordinates the phosphoserine. 
Mutating residues in the interface disrupted binding in vitro and caused defects in 
maintaining repressive chromatin in vivo. Overall, our results indicate that a direct 
interaction with the Rpb1 linker, but not the CTD, recruits Spt6 to sites of 
transcription where it functions to reassemble nucleosomes in the wake of 
RNAPII. 
 The work in this chapter was motivated by the binding studies discussed 
in Chapter 2. I performed all of the biochemical experiments presented. James 
Fulcher and Mark Petersen, in the laboratory of Michael Kay, synthesized the 
peptides. I solved the structure of the Spt6 tSH2-Rpb1 linker complex under the 
supervision of Frank Whitby. The laboratory of Tim Formosa performed all 
genetic experiments.  
 
Chapter 4: Identification of Tom1 as a Novel Binding Partner  
of the Spt6 Tandem SH2 Domain  
 The work in this chapter was performed in parallel with the work in 
Chapter 3 to identify alternative binding partners for the Spt6 tSH2 domain. 
Motivated by the work in Chapter 1, I performed a pull-down followed by far 
western blot to identify direct Spt6 tSH2 binding partners. Mass spectrometry 
identified a co-purifying protein that also bound in a far western blot as the E3 
ubiquitin ligase Tom1. Binding to Tom1 was found to be phosphorylation 
dependent and mediated through a central ~30 residue segment. Spt6 mutations 
that disrupt binding to RNAPII also disrupt binding to Tom1, and these 
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interactions are competitive. Deletion of the Tom1-Spt6 tSH2 binding region 
suppresses temperature sensitivity caused by Tom1 overexpression, suggesting 
a biological role for the interaction.  
 Since little is known about the Tom1 structure, we also determined an 8 Å 
reconstruction of full-length Tom1 using cryo-electron microscopy (cryo-EM). The 
structure reveals a lock washer shape composed primarily of helical repeats. 
Despite the paucity of recognizable domains, ~70-85% of the entire Tom1 
sequence is resolved. This work indicates that Tom1 is amenable to structure 
determination by cryo-EM and motivates pursuit of additional structures of Tom1 
complexes. 
 I performed all of the biochemical experiments presented. Mass 
spectrometry experiments were performed by the University of Utah core facility. 
James Fulcher and Mark Petersen synthesized the peptides. Cryo-EM data 
collection and analysis was performed with the assistance of Peter Shen and 
David Belnap. The laboratory of Tim Formosa created the Tom1 overexpression 
yeast strain and performed the genetic experiments. 
 
Chapter 5: Biochemical and Functional Characterization of  
the Spt6 Interaction with Histones H3-H4 
 The focus of this chapter was characterization of the Spt6 interaction with 
histones H3-H4. We show that the same Spt6 region that binds Spn1 is sufficient 
but not necessary for binding histones H3-H4. We identified mutations that 
disrupt the interaction with H3-H4 but not Spn1 in vitro, and these mutations 
cause phenotypes in vivo. We also find that Spt6 competes with DNA for H3-H4 
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binding. Overall, these results suggest that the Spt6-Spn1 binding region plays 
an important role in binding histones, but other binding surfaces likely exist. 
 This work was performed in close collaboration with Seth McDonald, who 
initiated these studies. Seth developed the fluorescence anisotropy binding 
assays and performed the DNA competition, ITC, and GST pull-down 
experiments. I performed the direct fluorescence anisotropy binding assays and 
identified mutations in the Spt6-Spn1 binding region that disrupt binding to H3-
H4. Members of the lab of Tim Formosa performed the genetic experiments. 
 
Chapter 6: Conclusions and Ongoing Research 
 Chapter 6 summarizes the findings of Chapters 2-5 and discusses the 
direction of future research, which will focus on Spt6 interactions and Tom1 
function. Further characterization of the phosphorylation events that regulate 
Spt6 interactions with RNAPII and Tom1 will help define how Spt6 is recruited to 
various processes. Towards this goal, we have raised an antibody that 
specifically recognizes the serine phosphorylated Rpb1 linker, and we will use it 
to determine the abundance of this modification throughout the transcription 
cycle. In addition, it will be of interest to identify the kinase(s) and phosphatase(s) 
that catalyze phosphorylation and dephosphorylation. I also show preliminary 
biochemical data suggesting that Spt6 can interact directly with the RNAPII core 
in the absence of the Rpb1 linker, potentially explaining the role of Spt6 in 
transcription elongation. I discuss efforts to characterize this interaction using 
cryo-EM. The unanticipated interaction between Spt6 and Tom1 raises questions 
about the functional importance of the interaction as well as how Tom1 
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participates in a variety of biological processes. I discuss experiments designed 
to dissect the biological relevance of the Spt6-Tom1 interaction. Finally, I suggest 
additional biochemical experiments to more thoroughly characterize Spt6 
interactions with histone H3-H4 and H2A-H2B. Overall, the experiments 
described in this chapter will build on data in this dissertation to further 
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MECHANISM OF PHOSPHORYLATION-DEPENDENT 
 





 Spt6 is a conserved factor with roles in several facets of gene expression 
including transcription elongation and nucleosome reassembly following RNAPII 
passage. The C-terminus of Spt6 contains a tandem SH2 domain that comprises 
the only known SH2 domains in yeast. The Spt6 tSH2 directly binds RNAPII and 
is necessary for maximum recruitment of Spt6 to genes. Previous studies 
suggest that Spt6 tSH2 binds the phosphorylated RNAPII CTD, but this model 
did not stand up to rigorous biochemical scrutiny. We show that the Rpb1 linker, 
but not the CTD, is necessary and sufficient for binding the Spt6 tSH2. This 
interaction is enhanced by phosphorylation of Rpb1 S1493, and is ~500 fold 
tighter than the interaction with CTD-derived peptides. A crystal structure of the 
Spt6 tSH2-Rpb1 linker complex reveals a novel Spt6 phosphate binding pocket 
that coordinates phosphorylated S1493 (pS1493). Mutations that destabilize the 
interface cause loss of transcriptional repression in S. cerevisiae. These results 
suggest that Rpb1 S1493 phosphorylation recruits Spt6 to elongating complexes 
where it functions to reassemble nucleosomes immediately following RNAPII 
passage. Identification of the Rpb1 linker as the authentic Spt6 tSH2 binding site
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 RNAPII is the twelve-subunit complex that transcribes all mRNAs and 
many noncoding RNAs. The largest subunit, Rpb1, contains a flexible C-terminal 
domain (CTD) consisting of heptad repeats of the consensus sequence 
Y1S2P3T4S5P6S7. Phosphorylation of the CTD on tyrosine, serine, and threonine 
residues provides a dynamic binding surface that recruits chromatin regulators 
and mRNA processing factors at specific stages of transcription (Eick and Geyer, 
2013). The CTD is tethered to the RNAPII core through a flexible ~80 residue 
linker. 
 Spt6 is a conserved transcription factor that co-localizes with RNAPII at 
sites of transcription (Kim et al., 2004; Mayer et al., 2010; Perales et al., 2013). It 
is essential in budding yeast and has multiple roles in gene expression including 
transcription, mRNA processing and export, histone posttranslational 
modification, and nucleosome positioning (Ardehali et al., 2009; Bucheli and 
Buratowski, 2005; Clark-Adams and Winston, 1987; Compagnone-Post and 
Osley, 1996; DeGennaro et al., 2013; Dronamraju and Strahl, 2014; Endoh et al., 
2004; Hartzog et al., 1998; Ivanovska et al., 2011; Kaplan et al., 2005; Perales et 
al., 2013; Yoh et al., 2007; Yoh et al., 2008). Spt6 reassembles nucleosomes in 
the wake of elongating RNAPII, thereby re-establishing a repressive chromatin 
state that prevents aberrant transcription initiation (Adkins and Tyler, 2006; 
DeGennaro et al., 2013; Hainer et al., 2011; Ivanovska et al., 2011; Kaplan et al., 
2003; Thebault et al., 2011). This activity is likely facilitated by direct interactions 
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with DNA, histones, and nucleosomes (Bortvin and Winston, 1996; Close et al., 
2011; McCullough et al., 2015; McDonald et al., 2010). In addition to chaperoning 
histones, Spt6 further influences chromatin state by promoting histone 
modifications that are associated with active transcription (DeGennaro et al., 
2013; Yoh et al., 2008). While altering chromatin state indirectly affects RNAPII 
elongation rates, Spt6 also stimulates RNAPII elongation on chromatin free DNA 
in vitro (Endoh et al., 2004; Yoh et al., 2007) and on permissive chromatin in vivo 
(Ardehali et al., 2009). These results establish Spt6 as a bona fide transcription 
elongation factor. 
 In addition to its roles in nucleosome assembly and transcription 
elongation, Spt6 is important for mRNA processing and export. In yeast, Spt6 
mutants are defective in transcription termination, 3’ processing, and mRNA 
export (Bucheli and Buratowski, 2005; Estruch et al., 2009; Kaplan et al., 2005). 
Consistent with these observations, Spt6 genetically interacts with the mRNA 
export factors Mex67 and Yra1 (Burckin et al., 2005; Estruch et al., 2009). In 
mammals, Spt6 is required for proper splicing of an HIV transcript and nuclear 
export of mRNA (Yoh et al., 2007). Furthermore, Spt6 physically associates with 
the RNA processing exosome in Drosophila (Andrulis et al., 2002).  
 Spt6 comprises 1,451 residues that can be roughly divided into three 
structural regions (Close et al., 2011). The N-terminal ~300 residues are highly 
acidic, predicted to be disordered, and necessary for binding both nucleosomes 
and the transcription factor Spn1 (Diebold et al., 2010a; McDonald et al., 2010). 
The core of Spt6 contains several domains with structural similarity to known 
  
69 
DNA and protein binding domains and has overall similarity to the prokaryotic 
transcription factor Tex (Johnson et al., 2008). The C-terminal ~200 residues 
comprise a tSH2 domain containing the only known SH2 domains in yeast (Close 
et al., 2011; Diebold et al., 2010b; Sun et al., 2010). The nSH2 domain 
resembles a canonical phosphotyrosine binding module, but the cSH2 domain 
appears cryptic.  
 The Spt6 tSH2 domain is important for Spt6 function in vivo. In yeast, 
deletion of the tSH2 domain causes slow growth and phenotypes attributed to 
defects in transcription elongation (Diebold et al., 2010b; Hartzog et al., 1998; 
McCullough et al., 2015; Sun et al., 2010). In mammals, the tSH2 domain is 
important for mRNA processing and export, and for class switch recombination 
(Begum et al., 2012; Okazaki et al., 2011; Yoh et al., 2007). Furthermore, 
deletion of the tSH2 domain reduces recruitment of Spt6 throughout transcribed 
genes (Burugula et al., 2014; Mayer et al., 2010). At least one activity of the Spt6 
tSH2 domain is direct binding to hyperphosphorylated RNAPII (Yoh et al., 2007).  
 The prevailing interpretation of the data is that Spt6 tSH2 binds RNAPII 
through the phosphorylated RNAPII CTD. While an attractive model, thorough 
biochemical analysis from several labs using different techniques does not 
support a biologically relevant interaction (Close et al., 2011; Diebold et al., 
2010b; Liu et al., 2011; Mayer et al., 2012; Sun et al., 2010). The affinities of 
Spt6 tSH2 for phosphorylated CTD-derived peptides were relatively weak in vitro 
(~1 µM to 5 mM depending on salt concentration, technique, and peptide), and 
there was little preference for different phosphorylation states, suggesting 
  
70 
nonspecific interactions. Consistent with a nonspecific interaction, Spt6 tSH2 
mutations expected to greatly alter binding to a phosphorylated peptide had only 
modest effects. Collectively, these observations suggest an alternative 
mechanism for Spt6 binding to RNAPII. 
  We show that Spt6 tSH2 directly binds the flexible, ~80 residue Rpb1 
linker that tethers the CTD to the RNAPII core. Importantly, this interaction 
requires phosphorylation of the Rpb1 linker on a specific, conserved serine 
residue. Using X-ray crystallography and biochemistry, we show that a novel 
phosphate-binding pocket in the cryptic Spt6 cSH2 domain coordinates the 
phosphoserine. Mutating the Spt6-Rpb1 linker interface in yeast causes the Spt- 
phenotype and cryptic promoter activation, suggesting defects in maintaining 
repressive chromatin. These data support a model in which Rpb1 linker 
phosphorylation recruits Spt6 to elongation complexes where it is positioned to 




The Rpb1 Linker Is Necessary for Spt6 tSH2 Binding 
 Spt6 tSH2 is thought to bind RNAPII through the CTD, but it has never 
been shown that the CTD is necessary for this interaction. The RNAPII CTD is 
required for viability, but insertion of protease sites adjacent to the CTD is 
tolerated (Li and Kornberg, 1994). We inserted PreScission Protease sites into 
Rpb1 that facilitated removal of the CTD (ΔCTD) or linker and CTD (Δlinker) 
during purification (Figures 3-1A and 3-1B). Purified RNAPII proteins were 




Figure 3.1. The Rpb1 linker is necessary for binding Spt6 tSH2. 
A) Schematic representation of full-length Rpb1 (WT) and deletion constructs 
tested for binding (ΔCTD and ΔLinker). 
B) Coomassie stained gel of purified RNAPII containing the Rpb1 constructs 
depicted in A. The Rpb3 subunit of ΔCTD and ΔLinker RNAPII has a residual 
calmodulin tag, causing slower migration compared to wild type. 
C) Far western blot using GST-Spt61223-1451 to probe a membrane containing the 
purified proteins shown in B. A western blot using an antibody that recognizes 
the N-terminus of Rpb1 was used to determine transfer efficiency. 
D) As in C, but the membrane was probed with free GST. 
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recombinant GST-Spt6 tSH2 (GST-Spt61223-1451) in a far western blot. Consistent 
with previous observations (Yoh et al., 2007), GST-Spt61223-1451 bound full-length 
Rpb1 (residues 1-1733) (Figure 3.1C). Free GST does not bind RNAPII, 
indicating that the interaction is specific to the tSH2 domain (Figure 3.1D). 
Surprisingly, Spt6 tSH2 retained complete binding to Rpb1 ΔCTD (residues 1-
1529). Removal of the 74 residue linker that tethers the CTD to the RNAPII core, 
however, abolished binding (Figure 3.1C).  
 A possible interpretation of these results is that Spt6 tSH2 can bind both 
the linker and CTD, such that binding is observed as long as at least one binding 
site is present. To address this, we identified residues that may contribute to 
binding by aligning Rpb1 linker sequences across eukaryotes. Just six residues 
that cluster into two groups of three are strictly conserved: Cluster 1) T1471, 
P1472, and Y1473 and Cluster 2) F1492, S1493, and P1494 (Figure 3.2A). We 
performed alanine scanning mutagenesis of these residues to see if they are 
important for binding in a far western blot (Figure 3.2B and C). Mutating residues 
in Cluster 1 modestly reduced binding with Rpb1T1471A having the largest effect. 
Mutating any of the residues in Cluster 2, on the other hand, greatly reduced 
binding. Bound Spt6 was reduced nearly to background in the Rpb1S1493A 
mutation and reduced 4.2 and 3.2 fold in Rpb1F1492A and Rpb1P1494A, respectively 
(Figure 3.2C). These results show that three conserved residues in the Rpb1 
linker are necessary for binding and indicate that the CTD is not sufficient for 





Figure 3.2. Mutating conserved residues in the Rpb1 linker disrupt binding 
even when the CTD is intact. 
A) Alignment of the Rpb1 linker across eukaryotic species. Rpb1 sequences from 
the indicated organisms were aligned using T-Coffee (Notredame et al., 2000) 
and visualized using ESPript (Robert and Gouet, 2014). Residues in the linker 
are shown and numbered according to the S. cerevisiae sequence. White 
characters on a red background represent strictly conserved residues and red 
font on a white background represents highly similar residues (global similarity 
score > 0.7). 
B) Far western blots testing Rpb1 linker mutants for binding to GST-Spt61223-1451. 
Transfer efficiency was determined by blotting with an antibody that recognizes 
the Rpb1 CTD (8WG16: Covance) 
C) Quantification of the far western blot. Ratios of the far western blot signal to 
the Rpb1 blot signal were calculated to corrected for differences in loading and 
transfer efficiency. Ratios were normalized to Rpb1. The averages from at least 




Spt6 tSH2 Binds Rpb1 Phosphorylated on Residue S1493 
 
 To determine if the Rpb1 linker is sufficient for Spt6 tSH2 binding, we used 
fluorescence anisotropy to quantify binding to a synthesized linker peptide with 
an N-terminal fluorescein (Fl-Rpb11476-1511). This peptide includes residues 
F1492, S1493, and P1494. The peptide bound purified recombinant Spt6 tSH2 
(Spt61247-1451) with a KD greater than 30 µM (Figure 3.2A), which is likely too weak 
to be detected in a far western blot. S1493 and P1494 form a minimal cyclin- 
dependent kinase phosphorylation site, prompting us to consider that binding 
could be enhanced by S1493 phosphorylation. We tested binding to Fl-Rpb11476-
1511 with S1493 phosphorylated (Fl-Rpb11476-1500 pS1493). The KD for the 
phosphorylated peptide was 70 nM, which is approximately 500 fold tighter than 
the unphosphorylated peptide (Figure 3.3A). Furthermore, the affinity is 
approximately 3 orders of magnitude tighter than phosphorylated CTD-derived 
peptides under the same buffer conditions (Close et al., 2011). Our assay was 
validated using a competitive fluorescence anisotropy experiment in which an 
unlabeled Rpb1 linker peptide was used to displace Spt61247-1451 from FL- 
Rpb11476-1511 pS1493. The KI in this assay was 138 nM, which is in reasonably close 
agreement with the KD observed in direct biding assays (Figure 3.3B). 
 Rpb1 S1493 phosphorylation has not been reported in the literature. To 
determine if this modification exists in vivo, we raised an antibody against a 
phosphorylated linker peptide. The specificity of the antibody for the 
phosphorylated peptide versus the unphosphorylated peptide was validated by 




Figure 3.3. Spt6 tSH2 binds the Rpb1 linker phosphorylated on S1493. 
A) Representative isotherms for Spt6 binding to Rpb1 linker peptides determined 
by fluorescence anisotropy. Spt61247-1451 was titrated into Fl-Rpb11476-1511 
peptides with or without S1493 phosphorylated. 
B) Competition fluorescence anisotropy assay. Unlabeled Rpb11476-1500 was 
titrated into constant concentrations of Spt61247-1451 (200 nM) and Fl-Rpb11476-1511 
pS1493 (0.5 nM). 
C) Binding affinities of Spt61247-1451 for Rpb1 linker peptides determined by 
fluorescence anisotropy. Error estimates shown are for the standard deviation 
determined from at least three independent experiments. 
D) Western blot on yeast whole cell extracts harboring wild type (WT) or mutant 
(S1493A) Rpb1 using an antibody raised against a phosphorylated peptide 
derived from the Rpb1 linker. 
E) Western blot on purified RNAPII with WT or S1493A versions of Rpb1 using 




resolved by SDS-PAGE (Figure 3.3D). Several bands were observed including a 
band that migrates at the same molecular weight as Rpb1. The intensity of this 
band is greatly diminished when S1493 is mutated to an alanine, confirming that 
the antibody preferentially recognizes the phosphorylated form of Rpb1. These 
observations were confirmed in a western blot with purified RNAPII (Figure 3.3E). 
Overall, these results demonstrate that Rpb1 S1493 is phosphorylated in vivo to 
promote binding to Spt6 tSH2.  
 
Crystal Structure of the Spt6 tSH2-Rpb1 Linker Complex      
 
 To understand how Spt6 tSH2 binds the serine phosphorylated linker, we 
determined a crystal structure of Spt6 tSH2 bound to a phosphorylated Rpb1 
peptide. The structure of Spt61247-1451 in complex with Rpb11476-1500 pS1493 was 
determined by molecular replacement using the coordinates of yeast Spt61247-1451 
(PDB: 3PSJ) (Close et al., 2011) and refined against 2.2 Å data to Rwork/Rfree 
values of 17.7/24.3 (Figure 3.4 and Table 3.1). The crystals contained one 
complex in the asymmetric unit. Spt6 residues T1250-R1451 and Rpb1 residues 
L1479-S1498 were visible in the electron density map. Spt6 residues 1441-1451 
were not ordered in previous crystal structures (Close et al., 2011), but are visible 
here due to lattice contacts. There is no density for the three N-terminal residues 
of Spt6 or the three N-terminal and two C-terminal residues of Rpb1, which are 
not included in the refined model. Binding to the Rpb1 linker did not induce 
conformational changes in Spt6 tSH2, which superimposes on unbound tSH2 
(PDB ID: 3PSJ) with an RMSD of ~0.52 Å over 189 pairs of Cα atoms.   




Figure 3.4. Structure of the Spt6 tSH2-Rpb1 linker complex. 
A) Spt6 tSH2 is shown as a surface representation colored by electrostatic  
surface potential (+kcal/(mol x e)). The nSH2 and cSH2 domains are indicated. 
The Rpb1 linker peptide is colored yellow and shown as sticks. A dashed orange 
circle indicates the putative Spt6 cSH2 phosphotyrosine binding pocket. The 
groove and hydrophobic cleft are highlighted by dashed peach and black boxes 
respectively. 
B) Orthogonal view of A. Colored as in A. The phosphoserine binding pocket is 
highlighted by a dashed magenta box. 

















Beamline Home source 
Wavelength 1.54178 
Space group C2221 
Unit cell dimensions: a, b, c (Å) 43.014, 103.54, 115.487 
Resolution 27.6-2.20 (2.3-2.2) 
Completeness (%) 89.81 (60) 
Redundancy 24.7 (17.0) 
Refinement 
Resolution 27.6-2.20 (2.3-2.2) 
Number of reflections 12,178 
Rwork/Rfree (%) 17.7/24.3 
Number of protein atoms 1,859 
Number of water molecules 83 
Rmsd bond lengths (Å)/angles (°) 0.007/0.878 
Ramachandran favored/allowed (%) 96.33/3.67 





domain, draping over the top of Spt6 tSH2 in an extended conformation that 
buries 1,194 Å2 of solvent accessible surface area. Extensive hydrophobic and 
polar contacts contribute to the interaction. The binding surface can be divided 
into three regions: a basic phosphoserine binding pocket, a hydrophobic cleft, 
and a shallow groove (Figure 3.4). The phosphoserine binding pocket is on the 
cSH2 domain on the tSH2 face opposite the putative phosphotyrosine binding 
pocket. It is formed by residues K1355, K1435, and Y1381 (Figures 3-4C and 3-
5A). pS1493 nestles in this pocket and forms hydrogen bonds between the 
phosphate and the amino groups of K1355 and K1435 as well as the hydroxyl 
group of Y1381. The amino group of Spt6 K1435 is also in position to hydrogen 
bond with the main chain carbonyl of P1494. This extensive network of hydrogen 
bonds explains the importance of phosphorylation for binding. The binding 
surface continues C-terminal to pS1493. In this region, Rpb1 L1496 makes van 
der Waals contacts with the hydrocarbon side chain of Spt6 K1435, and the main 
chain nitrogen and carbonyl of Rpb1 V1497 hydrogen bonds with the Spt6 N1432 
carboxamide. Additional interactions that are N-terminal to pS1493 are mediated 
through the Spt6 hydrophobic cleft and shallow groove. 
 The hydrophobic cleft formed by Spt6 residues Y1381, F1397, I1399, 
Y1406, W1408, F1434, and L1438 cuts through the top of Spt6 tSH2 (Figure 
3.4). Rpb1 residues F1492, L1490, and L1484 bury 411 Å2 of solvent accessible 
surface area in this cleft (Figure 3.5B and C). In addition to the hydrophobic 
interactions, several polar contacts contribute to binding in this region. The main 






Figure 3.5. Details of the Spt6-Rpb1 interface. 
A) Close up view of the pS1493 binding pocket. Spt6 is shown as a cyan ribbon 
with a semitransparent tan surface. Residues that contact Rpb1 are shown as 
sticks and labeled without boxes. Rpb1 is shown as yellow sticks. Residues that 
contact Spt6 are labeled in boxes with black borders. Hydrogen bonds are shown 
as black dashed lines. 
B) Close up view of the hydrophobic binding cleft. Colored as in A. 
C) Close up view of part of the hydrophobic binding cleft and the Rpb1 binding 





chain nitrogen of Spt6 S1379 and the carboxamide of Spt6 N1445, respectively. 
Additional hydrogen bonds are formed between the carboxylate groups of Rpb1 
E1489, D1488, and D1485 and the hydroxyl, carboxamide, and guanidinium 
groups of Spt6 Y1406, N1400, and R1446, respectively.  
 The shallow binding groove runs down the front of Spt6 cSH2 and adds 
moderate contributions to the binding surface (Figures 3-4A and 3-5C). The 
carboxamides of Rpb1 N1481 and Spt6 N1409 hydrogen bond as do the main 
chain carbonyl of Rpb1 A1482 and the indole nitrogen of Spt6 W1408. At the N-
terminus of Rpb1, L1479 contacts a hydrophobic patch formed by Spt6 W1392. 
Consistent with the groove contributing less to binding, the electron density for 
Rpb1 was not as strong in this region. 
 
Mutations in the Spt6 tSH2-Rpb1 Linker Interface  
 
Disrupt Binding In Vitro 
 
 Our structure explains the loss of Spt6 binding when Rpb1 F1492 is 
mutated or S1493 is not phosphorylated. To further validate the crystallographic 
interface, we measured binding affinities of purified Spt61247-1451 mutants to 
Rpb11476-1511 pS1493 using fluorescence anisotropy (Figure 3.6). The Spt6 K1435A 
protein bound Fl-Rpb11476-1511 pS1493 with a Kd greater than 10 µM, an ~150 fold 
reduction in affinity compared to wild type. Mutations in the canonical 
phosphotyrosine binding pocket (R1282A/S1284A), on the other hand, did not 
affect binding. These results validate the crystallographic interface and 
demonstrate the importance of phosphoserine binding pocket residues for 






Figure 3.6. Mutations in the Spt6-Rpb1 interface disrupt binding in vitro. 
A) Representative Spt6-Rpb1 binding isotherms determined by fluorescence 
anisotropy. Spt61247-1451 wild type (orange circles) and mutant (R1282A/S1282A, 
closed blue triangles; K1435A, open purple triangles) proteins were titrated into 
Fl-Rpb11476-1511 pS1493.  
B) Binding affinities based on experiments in A. Error estimates shown are for 





The Spt6 tSH2-Rpb1 Linker Interaction Is Important In Vivo 
 
 To determine the importance of Spt6 tSH2 binding to the Rpb1 linker in 
vivo, we introduced mutations that disrupt the interaction into the native SPT6 
and RPB1 genes at the normal genomic loci. All of the mutations caused the Spt- 
phenotype, indicating loss of transcriptional repression due to defects in 
chromatin maintenance (Figure 3.7A). Importantly, the severity of the phenotype 
correlated with the severity of the mutation on binding. The spt6-KK-AA mutant 
replaces the two lysines in the phosphoserine binding pocket with alanines, and 
causes a moderate Spt- phenotype. This phenotype was recapitulated by rpb1-
S1493, which eliminates phosphorylation by mutating Rpb1 S1493 to an alanine. 
The phenotypes of spt6-KK-AA and rpb1-S1493 are partially additive, suggesting 
that each allele causes only a partial loss of chromatin maintenance. This could 
indicate that each mutation results in a partial loss of binding, or that these 
interfaces have additional functions. A more severe Rpb1 mutation (rpb1-1490-
1495MKRRRK) that replaces residues L1490MFSPLV1496 with K1490MKRRK1496 
causes a very strong Spt- phenotype. These yeast are able to grow on media 
lacking lysine almost as well as on complete medium, suggesting that the Spt- 
phenotype is saturated. It is therefore unsurprising that the Spt- phenotypes of 
rpb1-1490-1495MKRRRK and spt6-KK-AA are not additive (Figure 3.7A), which 
is consistent with the model that interaction through these Rpb1 residues 
mediates the entire Spt- phenotype of Spt6.  
 Interestingly, this rpb1-1490-1495MKRRRK strain also displays activation 






Figure 3.7. The Spt6-Rpb1 interaction is important for maintaining 
repressive chromatin in vivo. 
A) Phenotypes of Spt6 and Rpb1 mutations integrated into the genomes of yeast 
at their native loci. spt6-KK-AA has alanine substitutions at K1355 and K1435 in 
the phosphoserine binding pocket. rpb1-S1493A has S1493 mutated to an 
alanine to prevent phosphorylation. rpb1-1490-1495KMKRRRK mutates residues 
L1490MFSPLV1496 to K1490MKRRK1496. Growth on medium lacking lysine (-lys) 
indicates the Spt- phenotype. Growth on medium containing galactose (Gal) and 
lacking histidine (-his) indicates activation of a cryptic promoter reporter.  
B) Schematic of the cryptic promoter reporter. Normal FLO8 has a cryptic TATA 
site in the 3’ end of the gene that is normally blocked by chromatin so it leads to 
very little transcription. Mutants that cause a defect in restoring chromatin to a 
normal repressive state after transcription of FLO8 lead to production of a short 
transcript containing only the 3’ end of the gene. The HIS3 gene was inserted 
into FLO8 downstream of the cryptic promoter and out of frame with the FLO8 
ORF. In normal cells, this leads to little expression of HIS3, but some mutants 
with a very strong defect become His+ due to cryptic transcription. Enhanced 
transcription of the region by induction of the strong Gal1 promoter increases the 
probability of cryptic promoter activation, and leads to a His+ phenotype with less 
severe mutations. Growth on Gal -his therefore reveals a defect in restoration of 






on chromatin integrity, but is specific to nucleosome reassembly during 
transcription (Figure 3.7B) (Cheung et al., 2008). In this yeast strain, the HIS3 
gene is inserted downstream of a cryptic promoter in the FLO8 gene. The cryptic 
promoter is normally repressed by chromatin, so these yeast should be unable to 
grow on media lacking histidine. Therefore, growth on media lacking histidine 
only when high levels of transcription are induced by the strong GAL1 promoter 
driving the reporter reveals a defect in restoring nucleosomes following 
transcription by RNAPII. This phenotype is enhanced by spt6-KK-AA, suggesting 
that rpb1-R3 retains partial Spt6 binding activity or these Spt6 residues have 
additional functions that contribute to chromatin maintenance during 
transcription. Collectively, these data validate the functional importance of the 
Spt6-Rpb1 interface that we have characterized biochemically and structurally, 
and implicate a role for the Spt6-Rpb1 interaction in reassembling repressive 
chromatin during transcription. Presumably, phosphorylation of Rpb1 S1493 
recruits Spt6 to elongating RNAPII complexes where it can facilitate reassembly 




 The Spt6 tSH2 domain comprises the only SH2 domains in yeast and is 
important for several aspects of Spt6 function including association with RNAPII. 
Spt6 tSH2 has been reported to mediate recruitment to RNAPII by directly 
binding the phosphorylated CTD. In contrast, we have shown that the CTD is 
neither necessary nor sufficient for Spt6 tSH2 binding. Rather, we find that Spt6 





enhanced ~500 fold when Rpb1 S1493 is phosphorylated. This phosphorylation 
event is seen to occur in vivo because an antibody that specifically recognizes 
this modification detected the epitope in western blots performed on whole cell 
extracts. This residue and the two flanking residues are strictly conserved 
throughout evolution, further suggesting functional importance. Consistent with 
this implication, mutating the serine to alanine causes defects in transcriptional 
repression in vivo. 
 Our crystal structure revealed that the Rpb1 pS1493 fills a basic pocket 
formed by Spt6 residues K1355, Y1381, and K1435 of the non-canonical cSH2 
domain. Mutation of K1435 to alanine reduced binding ~150 fold whereas 
mutations in the putative phosphotyrosine binding site had no effect. Yeast with 
mutations in the Spt6-Rpb1 interface are significantly impaired for transcriptional 
repression at promoters and in coding regions, suggesting that the interaction is 
important for nucleosome reassembly during transcription. Overall, these data 
suggest a model in which Rpb1 S1493 phosphorylation recruits Spt6 to 
elongation complexes where it is positioned to reassemble nucleosomes 
immediately following RNAPII passage. 
 To our knowledge, this is the first report of a specific function for the Rpb1 
linker. The linker is required for viability in S. cerevisiae (Suh et al., 2013), and 
the only reported role for the linker is to stabilize association of the Rpb4/7 
heterodimer with the core enzyme. This was inferred from a crystal structure of 
S. pombe RNAPII where the linker was substantially ordered due to contacts with 





our crystal structure reveals that the Spt6 tSH2 binding site on the linker overlaps 
with the region that contacts Rpb4/7. It is possible that the Spt6 tSH2-Rpb1 linker 
interaction contributes to transcriptional regulation by competing with the Rpb4/7-
Rpb1 linker interaction, but currently there is no direct evidence to support this 
possibility. 
 Our identification of the authentic RNAPII-Spt6 binding site changes the 
interpretation of published data. In the previously reported model, Spt6 binds the 
phosphorylated CTD. However, in ChIP experiments, Spt6 occupancy across 
genes does not correlate with the abundance of individual CTD phosphorylation 
marks, but it does correlate with total RNAPII occupancy (Mayer et al., 2012; 
Mayer et al., 2010). This could be explained by the interaction with the Rpb1 
linker if linker phosphorylation throughout the transcription cycle mimics Spt6 
occupancy. Therefore, an important area of future study will be to characterize 
the prevalence of S1493 phosphorylation across transcription units. The antibody 
that we raised in this study will be an important tool for pursuing this goal. 
 While phosphorylation of the CTD has been well studied, this is the first 
report of a biological role for phosphorylation of the Rpb1 linker, and has 
important implications for how Spt6 recruitment to genes is regulated. Since 
phosphorylation has such a profound effect on binding, understanding the 
kinase(s) and phosphatase(s) that control this modification is essential. Likely 
candidates include the CTD kinases Ctk1 and Bur1 that contribute to Spt6 
occupancy at the 5’ end of genes (Burugula et al., 2014), but others may exist. 





Spt6 interacts with RNAPII. Identification of the authentic Sp6 tSH2 binding site 
on RNAPII has important implications for Spt6 function and the direction of future 
research. To our knowledge, this is the first binding interaction and biologically 
relevant phosphorylation event described for the Rpb1 linker. Collectively, these 
data provide strong support for a model in which Spt6 directly binds elongating 
RNAPII to facilitate co-transcriptional reassembly of nucleosomes following 
RNAPII passage. 
 
Materials and Methods 
 
Plasmids  
 Plasmid pCK859, expressing S. cerevisiae Rpb1 (YCp_LEU2_Rpop21), 
has been described previously (Suh et al., 2010). For plasmids expressing 
mutant Rpb1, PCR fragments containing the desired mutation were ligated into 
the Sph1 and Xho1 sites of pCK859. Mutant PCR fragments were produced 
using overlap extension PCR as described previously (Saiki et al., Nucleic Acid 
Research, 1988). 
 Plasmids expressing His6 tagged Spt6 were described previously (Close 
et al., 2011). Plasmids expressing GST tagged Spt6 were produced by inserting 
the Spt61223-1451 coding sequence into the pDEST15 vector (Thermo Fisher 













 Yeast strain MAS015 was created by integrating a PreScission Protease 
Protein A tag into the C-terminus of the RPB3 gene in the protease-deficient 
yeast strain 7382 (from Tim Formosa). This strain was used for purification of 
wild type RNAPII.  
 Yeast strain 9138-4-2 (derived from CKY283, which has been described 
previously; Kaplan et al., 2008; Larson et al., 2012) contains a TAP tag at the C-
terminus of the RPB3 gene, a disrupted genomic RPB1, and expresses Rpb1 
from a plasmid (pRP112_YCp URA3). The strain was transformed with mutant 
Rbp1 plasmids, and loss of the URA3 plasmid was selected by plating on 5-FOA 
(5-fluoroorotic acid). These strains were used to purify RNAPII with Rpb1 
mutants. 
 Yeast strains used for assaying phenotypes were created and scored in 
the laboratory of Tim Formosa.  
 
Protein Expression and Purification 
 
 S. cerevisiae RNAPII was purified from yeast strains containing either a 
PreScission Protease cleavable Protein A tag (wild type) or TAP tag (Rpb1 
mutants) at the C-terminus of the Rpb3 subunit. RNAPII ΔCTD, Δlinker, and 
Rpb1 point mutants were purified from yeast expressing Rpb1 from a plasmid. 
Six liters of YPD (yeast extract peptone dextrose) were inoculated with 100 ml of 
a saturated overnight culture and incubated at 30°C for 2 days. Cells were 
harvested by centrifugation, washed once with cold water, and pelleted by 





nitrogen. Frozen cells were lysed under liquid nitrogen using a SPEX 
SamplePrep 6870 Freezer/MillTM.  
 Pulverized yeast were rehydrated and thawed in 1 pellet equivalent of 
lysis buffer (50 mM Tris pH 7.5, 500 mM KCl, 10% glycerol, 0.1% Tween-20, 10 
µM ZnCl2, 1 mM DTT, 2x pepstatin, 2x leupeptin, 2x aprotinin, 2x PMSF). Lysate 
was clarified by centrifugation at 37,000 RCF for 30 minutes. The supernatant 
was incubated with 2 ml of IgG sepharose resin (MP Biomedicals cappelTM 
antigen affinity gel) for 1 hour, followed by 6 washes with 4 ml of lysis buffer. 
Proteins were eluted by incubating with 4 ml of lysis buffer containing 100 µg 
PreScission Protease overnight at 4°C. In the morning, the supernatant was 
collected and the resin washed with 4 ml of lysis buffer. The supernatant and 
wash were pooled and diluted 4 fold with buffer QA (20 mM Tris-acetate pH 7.5, 
0.5 mM EDTA, 10 µM ZnCl2, 10% glycerol, 1 mM DTT). The sample was further 
purified via anion exchange chromatography (5 ml Hi-Trap Q column) using a 
gradient from 150 mM to 1,500 mM KOAc. The RNAPII peak fractions were 
collected, concentrated to 10 ml, and diluted 2 fold with buffer QA to reduce the 
salt concentration. RNAPII was exchanged into storage buffer (25 mM HEPES 
pH 7.5, 150 mM KOAc, 10 µM ZnCl2, 10% glycerol, 5 mM DTT) by serial 
concentration and dilution. RNAPII was concentrated to ~5 µM and flash frozen 
in liquid nitrogen prior to storage at -80°C. 
 Spt61247-1451 proteins were expressed and purified as described previously 
(Close et al., 2011). GST-Spt61223-1451 expression and purification was similar 









 Peptides were synthesized and purified by James Fulcher in the 
laboratory of Michael Kay. 
 
Far Western Blots 
 Far western blots were performed as described previously (Wu et al., 
2007). Briefly, 2.3 pmol of purified RNAPII was separated by SDS-PAGE on 
NuPAGE™ Novex™ 4-12% Bis-Tris Protein Gels (Invitrogen) electrophoresed in 
MOPS buffer, transferred to nitrocellulose membranes, and denatured in 
guanidine HCl. Proteins were renatured by stepwise incubation with protein 
binding buffer (20 mM Tris pH 7.5, 100 mM NaCl, 0.5 mM EDTA, 10% glycerol, 
0.1% Tween-20, 2% skim milk powder, 1 mM DTT) containing decreasing 
concentrations of guanidine HCl and incubated with blocking buffer [3% milk in 
TBS (25 mM Tris, 137 mM NaCl, 2.7 mM KCl)] for 1 hour at room temperature. 
Membranes were incubated with protein binding buffer containing 25 µM GST or 
GST-Spt61223-1451 overnight at 4°C. Membranes were washed 3 times with TBS-T 
(TBS with 0.05% Tween-20) and incubated with anti-GST antibody produced in 
goat (GE Healthcare 27-4577-01) diluted 1:1,000 in blocking buffer. After 
washing 3 times with TBS-T, membranes were incubated with a 1:10,000 dilution 
of infrared-labeled antisera that recognizes goat IgG. Bound proteins were 









 Yeast whole cell extracts were prepared using the trichloroacetic acid 
(TCA) method as described previously (McCullough et al., 2015). Protein 
concentrations were determined using the PierceTM BCA Protein Assay Kit, and 7 
µM total protein was separated by SDS-PAGE. Rpb1 was detected with primary 
antibodies y-80 (Santa Cruz) or 8WG16 (Covance) that recognize the N-terminal 
region or CTD, respectively, and infrared-labeled secondary antibodies.  
 Polyclonal antisera that specifically recognizes Rpb1 pS1493 was 
produced by Covance. Briefly, rabbits were injected with the Rpb1 linker-derived 
peptide CDVKDELMF(pS)PLVDSGSN conjugated to KLH. The exsanguination 
bleed was subjected to positive and negative affinity purification steps over 
columns consisting of the phosphorylated peptide or unphosphorylated peptide 
respectively. The specificity for the phosphorylated peptide versus the 




 For direct binding assays, purified Spt61247-1451 was dialyzed overnight into 
anisotropy buffer (15 mM Tris pH 7.5, 100 mM NaCl, 5% glycerol, 0.5 mM EDTA 
pH 8.0, 2 mM BME) and titrated in 2 fold serial dilutions against a constant 
concentration (~0.5 nM) of fluorescently labeled peptide. Reactions were 
incubated for 20 minutes at 25°C and fluorescence anisotropy was measured 
using a BioTek Synergy Neo Microplate Reader set to 485 nm/535 nm 
excitation/emission wavelengths. KD values were determined by fitting the data in 





[pep]) × (([pro] + [pep] + KD) – (([pro] + [pep] + KD)
2 – 4 × [pro] × [pep])1/2) (LiCata 
and Wowor, 2008), where A is the measured anisotropy, AT is the total change in 
anisotropy, [pep] is the peptide concentration, and [pro] is the protein 
concentration. 
 For competition experiments, Spt61247-1451 and unlabeled peptides were 
dialyzed overnight into anisotropy buffer. The unlabeled peptide was titrated in 
1.8 fold serial dilutions against constant concentrations of fluorescently labeled 
peptide (~0.5 nM) and Spt61247-1451 (200 nM). Reactions were incubated for 20 
minutes at 25°C prior to measuring anisotropy. Kd values for the unlabeled ligand 
were determined by fitting the data in GraphPad Prims® using nonlinear least 
squared regression against the exact expression for competitive binding (Wang, 
1995). The KD of the labeled ligand, the concentration of labeled ligand, and the 




 86 µM Spt61247-1451 was mixed with a 2 fold molar excess of Rpb11476-1500 
pS1493 and concentrated. Crystals were grown at 4°C by vapor diffusion. Drops 
comprised 0.4 µl of 14 mg/ml protein and 0.2 µl well solution (40% ethanol, 100 
mM Tris pH 7.0) (#7 of the Cryo II screen; Emerald BioSystems). Crystals were 
cooled by plunging into liquid nitrogen. Data were processed and scaled with 
HKL2000. The structure was determined by molecular replacement with Phaser 
(CCP4 program suite) using the coordinates of the yeast Spt6 tSH2 domain 
(PDB: 3PSJ) as the search model. Model building and refinement were 
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IDENTIFICATION OF TOM1 AS A NOVEL BINDING 
 





 Spt6 is involved in several facets of gene expression including 
transcription elongation, chaperoning histones, and exporting mRNA. The C-
terminus of Spt6 consists of a tSH2 domain comprised of the only SH2 domains 
predicted in yeast. The tSH2 domain contributes to Spt6 function and is 
necessary for maximal recruitment to sites of transcription. Binding interactions 
are likely central to Spt6 tSH2 function. The only published binding partner for 
Spt6 tSH2 is the phosphorylated CTD of RNAPII, but rigorous biochemistry 
suggests that this is a nonspecific interaction. In this work, we used pull-downs, 
mass spectrometry, and far western blotting to identify direct Spt6 tSH2 binding 
partners. We found that the tSH2 domain specifically binds the E3 ubiquitin 
ligase Tom1. This interaction requires Tom1 phosphorylation and was mapped to 
a central 30 residue fragment in a highly acidic region that competes with RNAPII 
for binding. Deletion of the Tom1-Spt6 binding region in S. cerevisiae suppresses 
temperature sensitivity caused by Tom1 overexpression, indicating that the 
interaction is biologically important. A cryo-EM reconstruction of Tom1 reveals a 
highly structured protein composed primarily of helical repeats. Overall, the data 
  
100 
presented in this chapter establish Tom1 as a biologically relevant binding 





 Spt6 is a highly conserved factor that is essential in yeast (Clark-Adams 
and Winston, 1987). Since its initial discovery in a genetic screen for factors 
required for normal transcription initiation (Winston et al., 1984), Spt6 has been 
implicated in several facets of gene expression including transcription elongation 
and termination, mRNA processing and export, posttranslational modification of 
histones, and nucleosome positioning (Ardehali et al., 2009; Bucheli and 
Buratowski, 2005; Clark-Adams and Winston, 1987; Compagnone-Post and 
Osley, 1996; DeGennaro et al., 2013; Dronamraju and Strahl, 2014; Endoh et al., 
2004; Hartzog et al., 1998; Ivanovska et al., 2011; Kaplan et al., 2005; Perales et 
al., 2013; Yoh et al., 2007; Yoh et al., 2008). The diverse roles of Spt6 are 
important for a variety of biological processes such as embryogenesis in 
Zebrafish (Keegan et al., 2002; Kok et al., 2007), multiple stages of development 
in Drosophila (Ardehali et al., 2009), gut morphogenesis in C. elegans (Nishiwaki 
et al., 1993), and HIV transcriptional regulation (Vanti et al., 2009; Yoh et al., 
2007).  
 An important role of Spt6 is to chaperone histones to reassemble 
nucleosomes in the wake of elongating RNAPII in order to repress aberrant 
transcription initiation (Adkins and Tyler, 2006; DeGennaro et al., 2013; Hainer et 
al., 2011; Ivanovska et al., 2011; Kaplan et al., 2003; Thebault et al., 2011). In 
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addition to its function as a histone chaperone, Spt6 is a transcription elongation 
factor that is capable of stimulating RNAPII elongation rates (Ardehali et al., 
2009). This activity appears to be independent of Spt6 histone chaperone activity 
because Spt6 enhances RNAPII elongation rates in vitro on nucleosome-free 
DNA templates (Endoh et al., 2004; Yoh et al., 2007). Furthermore, Spt6 appears 
to coordinate the transcription cycle with mRNA processing and export because 
genetic and physical interactions have been reported between Spt6 and the 
mRNA processing and export machinery (Andrulis et al., 2002; Burckin et al., 
2005; Estruch et al., 2009). Spt6 has several known activities that contribute to 
these diverse functions including binding to RNAPII, histones, DNA, 
nucleosomes, and Spn1 (Bortvin and Winston, 1996; Close et al., 2011; Diebold 
et al., 2010a; McCullough et al., 2015; McDonald et al., 2010; Yoh et al., 2007). 
 Spt6 is approximately 168 kDa and can be divided into three structural 
regions: an ~300 residue N-terminal region that is highly acidic and natively 
unstructured, a core that resembles the prokaryotic transcription factor Tex, and 
a C-terminal tSH2 domain (Close et al., 2011; Johnson et al., 2008). The tSH2 
domain contains the only known SH2 domains in yeast and is conserved 
throughout eukaryotes (Close et al., 2011; Diebold et al., 2010b; Sun et al., 
2010). Spt6 tSH2 is important for several facets of Spt6 function including 
maximal recruitment to genes, transcription elongation, maintenance of 
repressive chromatin, and mRNA processing and export (Burugula et al., 2014; 
Endoh et al., 2004; Hartzog et al., 1998; Mayer et al., 2010; Yoh et al., 2007). 
The only known activity of Spt6 tSH2 is direct binding to the phosphorylated 
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Rpb1 linker (discussed in Chapter 3), but this interaction had not been 
characterized when this work was initiated.  
 To better understand Spt6 tSH2 function, we took an unbiased approach 
to identify Spt6 tSH2 binding partners. We used mass spectrometry to identify 
factors that co-purify with Spt6 tSH2 over two affinity columns, and far western 
blots to identify direct binding partners. We identified the E3 ubiquitin ligase 
Tom1 as a novel Spt6 tSH2 binding partner. Tom1 is a 375 kDa protein that is 
homologous to mammalian Huwe1 (also called Huwe1/Mule/Lasu/Ureb1/Arf-
BP1/HectH9/E3Histone; Ptr1, Upl1, and Eel1) and has a C-terminal HECT domain. 
In humans, mutations in the gene encoding Huwe1 are associated with cancer 
and intellectual disability (Froyen et al., 2012; Froyen et al., 2008; Inoue et al., 
2013; Isrie et al., 2013; Liu et al., 2012; Nava et al., 2012; Zhao et al., 2009). 
Tom1 has roles in mRNA processing and export, degradation of excess histones, 
transcription, and cell cycle regulation (Duncan et al., 2000; Iglesias et al., 2010; 
Kim and Koepp, 2012; Kim et al., 2012; Liu et al., 2005; Saleh et al., 1998; Singh 
et al., 2009; Utsugi et al., 1999). Our work shows that Spt6 directly binds a 
phosphorylated central 27 residue fragment of Tom1 that contributes to 
temperature sensitivity when Tom1 is overexpressed. Furthermore, we used 
cryo-EM to determine the structure of Tom1, and find that it folds into a single 











Spt6 Co-Purifies with RNAPII, Yra1, and Tom1 
 To identify factors that physically associate with Spt6 tSH2, we over- 
expressed tandem Strep-FLAG tagged Spt6 tSH2 (SF-Spt61223-1451) in yeast and 
performed tandem affinity purification (SF-TAP) (Gloeckner et al., 2007). The 
elution was resolved by SDS-PAGE and bands were excised for identification by 
mass spectrometry (Figure 4.1A). The background was very low, with no proteins 
apparent when the tandem affinity purification was performed from yeast 
transformed with an empty plasmid. The procedure was further validated by the 
strong co-purification of RNAPII, a known Spt6 tSH2 binding partner (Yoh et al., 
2007). Many of the low molecular weight proteins were ribosomal proteins, which 
are common contaminants in this type of assay. In addition to ribosomal proteins, 
the 25 kDa mRNA export factor Yra1 and the 375 kDa E3 ubiquitin ligase Tom1 
co-purified with SF-Spt61223-1451.  
 In order to determine if the associations with Yra1 and Tom1 were direct, 
we tested for Spt6 tSH2 binding in a far western blot. The SF-TAP elution 
samples were resolved by SDS-PAGE and transferred to a membrane. The 
membrane was probed with either purified recombinant GST-Spt61223-1451 or free 
GST and detected with antibodies against GST. As shown previously, Spt61223-
1451 bound Rpb1, the largest subunit of RNAPII (Yoh et al., 2007). In addition, 
Spt61223-1451 also bound Tom1 (Figure 4.1B). Free GST does not bind, confirming 
that the interaction with Tom1 is specific to Spt6 tSH2 (Figure 4.1C). GST-





Figure 4.1. Spt6 tSH2 binds Tom1.  
A) Coomassie stained gel of SF-TAP-purified SF-Spt61223-1451 expressed in yeast. 
Gel bands were excised and identified using mass spectrometry.  
B) SF-TAP elutions were transferred to a membrane and used for far western 
blots with purified recombinant GST-Spt61223-1451 as a probe. 
C) SF-TAP elutions were transferred to a membrane and used for far western 
blots with purified recombinant GST as a probe. 
D) Tom1 was overexpressed in yeast and purified. Purified Tom1 was transferred 
to a membrane and used for far western blots with purified recombinant GST-
Spt61223-1451 as a probe. 
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and is possibly mediated by mutual binding partners such as RNAPII or Tom1 
(Iglesias et al., 2010; MacKellar and Greenleaf, 2011).  
 To verify the interaction with Tom1, we tested binding to highly purified 
Tom1. Tom1 with a C-terminal protein A tag was overexpressed in yeast under 
control of the GAL1-GAL10 promoter and was purified (Figure 4.1D). A faster 
migrating degradation product co-purified with full-length Tom1. Purified Tom1 
was transferred to a membrane and tested for Spt6 tSH2 binding in a far western 
blot. Consistent with the far western blot using the SF-TAP sample, GST-
Spt61223-1451 interacted with purified Tom1 (Figure 4.1D). Collectively, these 
results establish Tom1 as a previously unidentified Spt6 tSH2 binding partner. 
 
Spt6 tSH2 Binds Phosphorylated Tom1 
 
 Since Spt6 tSH2 is known to bind phosphorylated proteins, we tested if 
the interaction with Tom1 is phosphorylation-dependent. Purified Tom1 was 
treated with calf intestinal alkaline phosphatase (CIP) prior to far western blotting 
with GST-Spt61223-1451. Treatment with CIP led to greatly reduced binding 
compared to untreated Tom1 (Figure 4.2B), indicating that phosphorylation 
contributes to binding. Because Spt6 tSH2 also binds phosphorylated Rpb1, we 
tested if Spt6 tSH2 binds Tom1 using the same binding pocket. The Spt6 
K1435A mutation in the Spt6 cSH2 phosphoserine binding pocket disrupts the 
interaction with Rpb1, and this mutation eliminated binding to Tom1 in a far 
western blot (Figure 4.2B). These results suggest that Spt6 tSH2 binds 




Figure 4.2. Spt6 tSH2 binds phosphorylated Tom1 through the cSH2 
domain phosphoserine binding pocket. 
A). Purified Tom1 was untreated (-CIP) or treated (+CIP) with CIP prior to SDS-
PAGE and far western blotting with GST-Spt61223-1451. –CIP and +CIP were on 
the same gel and membrane, but intervening lanes were removed for clarity. 
B) SF-TAP elutions were subjected to far western blotting with GST-Spt61223-1451 
(WT) or GST-Spt61223-1451 K1435A (K1435A).  
C) K1435A is a mutation in the cSH2 domain phosphoserine binding pocket that 
is important for binding Rpb1. Surface representation of the Spt6 tSH2 crystal 
structure (PDB ID: 3PSI) with the phosphoserine binding pocket highlighted with 
a dashed circle and K1435 colored red. Figure generated using UCSF Chimera 
(Pettersen et al., 2004). 
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Mapping the Tom1-Spt6 tSH2 Binding Site 
 
 Tom1 is a large protein (3,268 residues) with little predicted domain 
architecture (Figure 4.3A). To narrow down the region on Tom1 where Spt6 tSH2  
binds, we subjected purified Tom1 to limited proteolysis and tested the resulting 
fragments for Spt6 tSH2 binding in a far western blot (Figure 4.3B). Despite 
having few recognizable domains, Tom1 is surprisingly resistant to proteolysis 
with an ~250 kDa fragment surviving up to 30 minutes in the presence of trypsin. 
This fragment retained binding to Spt6 tSH2 as did an ~60 kDa fragment whose 
appearance correlated with disappearance of the 250 kDa fragment. To map the 
60 kDa fragment to the Tom1 sequence, we identified tryptic peptides using 
mass spectrometry. The majority of the peptides mapped to a central region of 
the Tom1 sequence that lacks recognizable structural motifs (Figure 4.3A). 
Because Tom1 binds the same Spt6 tSH2 interface as the Rpb1 linker, we 
reasoned that binding might be mediated through a similar sequence motif. By 
comparing the Spt6 tSH2-Rpb1 linker structure to Rpb1 sequence conservation, 
we identified three Rpb1 residues that contribute to the interface and are highly 
conserved (Figure 4.3C). Rpb1 L1490 is always a hydrophobic residue and 
F1492 and S1493 are strictly conserved. Given this insight, we searched Tom1 
for the sequence Hb-x-F-S where Hb is any hydrophobic residue. Of the six 
candidate sequences in Tom1 that matched the motif, only one mapped to the 
sequence near the minimal binding fragment identified by mass spectrometry 
and was conserved throughout yeast (Figure 4.3D). Notably, the residue aligned 




Figure 4.3. Tom1 residues 1921-1947 are necessary for binding Spt6 tSH2. 
A) Schematic representation of Tom1 with predicted domains highlighted. Red 
lines represent peptides that were identified in the Spt6 binding fragment by 
mass spectrometry. 
B) Purified Tom1 was partially proteolyzed by incubating with trypsin from 30 
seconds to 30 minutes. Time points were resolved by SDS-PAGE and stained 
with coomassie or subjected to far western blotting with GST-Spt61223-1451 as a 
probe. Peptides in a ~60 kDa fragment that retained binding to Spt6 were 
identified using mass spectrometry (black arrowhead). 
C) A candidate Tom1-Spt6 tSH2 binding site. The Tom1 sequence was searched 
for sequences that match the Rpb1 linker motif Hb-x-F-S, where Hb is any 
hydrophobic residue and x is any residue. Of the five hits, only one mapped to 
the Spt6 binding region, and was conserved throughout yeast  
D) Alignment of the candidate Tom1-Spt6 tSH2 binding region (S. cerevisiae 
residues 1917-1951). Tom1 sequences from different yeast species were aligned 
using ConSurf (Ashkenazy et al., 2010) and ESPript (Robert and Gouet, 2014) 
was used for visualization. White characters on a red background represent 
invariant residues and red font on a white background represents highly similar 
(global similarity score > 0.7) residues. Asterisks mark the residues matching the 
Hb-x-F-S motif highlighted in C. 
E) Far western blot against full-length Tom1 (FL) and Tom1 Δ1921-1947 using 
GST-Spt61223-1451 as a probe. 
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aligned with Rpb1 S1493 is always a serine or a threonine, which can generally 
be phosphorylated like serine. To determine if this sequence is in fact the Spt6 
tSH2 binding site, we tested binding to Tom1 lacking residues 1921-1947 
(Tom1Δ1921-1947), and found that GST-Spt612223-1451 binding was greatly reduced 
(Figure 4.3E). These results indicate that Tom1 residues 1921-1947 and 
phosphorylation, presumably of S1943, are necessary for binding Spt6 tSH2.  
 
Tom1 1921-1951 Is Sufficient for Binding Spt6 tSH2 
 
 To determine if this region of Tom1 is sufficient for binding, we had a 
fluorescently labeled peptide spanning residues 1921-1951 synthesized with 
S1943 phosphorylated (Fl-Tom11921-1951 pS1943). Fluorescence anisotropy was 
used to measure the binding affinity of purified recombinant Spt61247-1451 to Fl-
Tom11921-1951 pS1943. The binding constant (KD) was 80 nM (Figure 4.4A), which is 
very similar to the KD observed for the Rpb1 linker peptide. Our assay was 
validated using a competition experiment in which unlabeled Tom11921-1951 pS1943 
peptide was used to compete with the labeled peptide for Spt61247-1451 binding. 
The inhibition constant (KI) in this assay was 240 nM, which is in reasonably 
close agreement with the KD observed in direct binding assays (Figure 4.4B). 
This result indicates that the dye is not substantially interfering with or 
contributing to binding (Figure 4.4B). Because the Spt6 K1435A mutant reduced 
binding in the far western blot, we used fluorescence anisotropy to quantify the 
reduction in binding. Spt61247-1451 K1435A bound Tom11921-1951 pS1943 with a KD of 5.6 
µM, a reduction in affinity of 70 fold relative to wild type (Figure 4.4A). 




Figure 4.4. Tom1 1921-1951 phosphorylated on S1493 is sufficient for 
binding Spt6 tSH2 and competes with the Rpb1 linker. 
A) Fluorescence anisotropy binding assay. Spt61247-1451 wild type (WT, orange 
circles) or K1435A (red squares) were titrated into Fl- Tom11921-1951 pS1943. 
B) Competition fluorescence anisotropy binding assay. Unlabeled Tom11921-1951 
pS1493 was titrated into constant concentrations of Spt61247-1451 (1 µM) and Fl-
Tom11921-1951 pS1943 (0.5 nM). 
C) Competition fluorescence anisotropy binding assay. Unlabeled Tom11921-1951 
pS1493 was titrated into constant concentrations of Spt61247-1451 (1 µM) and Fl-
Rpb11476-1511 pS1493 (0.5 nM). 
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also important for RNAPII binding, we used a competition fluorescence 
anisotropy assay to determine if the interactions are competitive. Unlabeled 
Tom11921-1951 pS1943 was titrated into constant concentrations of Spt61247-1451 and 
fluorescently labeled Rpb11476-1511 pS1493A, and fluorescence anisotropy was 
measured. Tom11921-1951 pS1943 competed with Rpb11476-1511 pS1493A for Spt6 tSH2 
binding with a KI of 320 nM, consistent with the Ki determined using Fl-Tom11921-
1951 pS1943. These results indicate that Tom1 and RNAPII compete for Spt6 tSH2 
binding and have similar affinities. 
 
The Spt6 tSH2-Tom1 Interaction Is Important In Vivo 
 
 We used yeast genetics to determine if the Spt6 tSH2-Tom1 interaction is 
important in vivo. Tom1 deletion causes severe temperature sensitivity (Utsugi et 
al., 1999; Utsugi et al., 1995), but deletion of just the Tom1-Spt6 tSH2 binding 
domain (Tom1Δ1926-1947) does not. Overexpressing Tom1 also causes a 
temperature sensitive phenotype, but overexpressing Tom1Δ1926-1947, on the other 
hand, does not (data not shown); therefore, temperature sensitivity caused by 
Tom1 overexpression is likely related to Spt6 tSH2 binding, with one possibility 
being sequestration of Spt6 from RNAPII. Importantly, these results establish that 
the Spt6 interaction with Tom1 is relevant in vivo; however, at this point, the 




 The resistance of Tom1 to proteolysis (Figure 4.4B) suggested that it is 
substantially folded. This was unexpected, as the four recognizable sequence 
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domains comprise less than 30% of the total sequence. The overall domain 
organization and large size of Tom1 has been conserved throughout evolution, 
suggesting that they are important features for Tom1 function. The specific 
domains of unknown function (DUF) seen in Tom1 are only found in Tom1 
homologues, but no structural information is available. Notably, the sequences of 
DUF908 and DUF913 belong to a superfamily that contains helical repeat 
proteins. In order to better understand the structural and mechanistic details of 
Tom1 function, we set out to determine the structure.  
 Due to the large size of Tom1, we pursued single particle cryo-EM instead 
of x-ray crystallography. Tom1 purified from yeast eluted from a size exclusion 
column at an apparent molecular weight of ~480 kDa, which is consistent with a 
slightly elongated monomer (Figure 4.5A). Tom1 was imbedded in vitreous ice 
and imaged using cryo-EM, revealing numerous doughnut and horseshoe 
shaped particles (Figure 4.5B). 2D class averaging was used to discard bad 
particles and contaminants. The resulting good particles segregated into 2D 
class averages representative of multiple orientations with secondary structure 
features clearly visible (Figure 4.5C). 3D reconstruction with the clean data set 
yielded an 8 Å resolution structure of Tom1 that was sufficient to resolve alpha 
helices (Figure 4.5D and E).  
 The structure reveals an overall shape that resembles a lock washer 
consisting primarily of helical repeats. We were unable to dock the crystal 
structure of the HECT domain from Huwe1 (Pandya et al., 2010) into the density 




Figure 4.5. 8 Å cryo-EM structure of Tom1. 
A) Size exclusion chromatogram of Tom1 injected on a Superdex 200 column. 
Tom1 elutes in a symmetric peak at a molecular weight of 480 kDa, consistent 
with an elongated monomer. Peak fractions were resolved using SDS-PAGE and 
stained with coomassie. 
B) Purified Tom1 was frozen in vitreous ice and imaged using a TF20 
microscope (FEI) and a K2 direct electron detector (Gatan).  
C) Representative 2D class averages of Tom1. 
D). Orthogonal views of an 8 Å Tom1 3D reconstruction. 
E) A zoomed in view of the helical repeats showing resolution sufficient to see 
secondary structure features. 
Figures D and E were generated using UCSF Chimera (Pettersen et al., 2004). 
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probably due to mobility relative to the rest of the structure. In addition, an ~300 
residue region of Tom1 is highly acidic and predicted to be disordered, so it is 
unlikely to be resolved in the reconstruction. Excluding the HECT domain and the 
acidic region, there are ~305 kDa that could be structured. By comparing the 
volume of the Tom1 map to maps from published structures, we estimate that 
~250-300 kDa of Tom1 are visible in our reconstruction, accounting for the 
majority of the Tom1 sequence except for the HECT domain and the acidic 
region. Therefore, despite minimal recognizable domains predicted by sequence, 




 We used SF-TAP followed by far western blotting and mass spectrometry 
to identify binding partners of the Spt6 tSH2 domain. Consistent with the work 
presented in Chapter 3, this analysis identified Rpb1 as an Spt6 tSH2 binding 
partner. Surprisingly, we found that the E3 ubiquitin ligase Tom1 also interacts 
directly with Spt6 tSH2. We further determined that Tom1 residues 1921-1947 
are necessary for this interaction as is phosphorylation of S1943. Moreover, a 
phosphorylated Tom1 peptide binds Spt6 tSH2 with an affinity similar to Rpb1, 
and these interactions are competitive. 
 The biological relevance of the Spt6-Tom1 interaction is unclear, but our 
genetic data indicate that it is important. An attractive model is that the 
competition between RNAPII and Tom1 for Spt6 binding serves as a switch that 
signals the end of the transcription cycle. For example, the switch from RNAPII to 
Tom1 binding could be a checkpoint in mRNA maturation and export. Tom1 is 
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thought to ubiquitylate Yra1 in order to facilitate its removal from mRNA prior to 
nuclear export (Iglesias et al., 2010). Spt6 may recruit Tom1 to the nascent 
mRNA after transcription is complete, signaling Tom1 to ubiquitylate Yra1. This 
would ensure that Yra1 is only ubiquitylated when associated with a completely 
transcribed message, preventing nuclear export of truncated mRNAs. Consistent 
with this, Spt6 and Tom1 are each important for efficient nuclear export of mRNA 
and both associate with the mRNA export factor Yra1 (Estruch et al., 2009; 
Iglesias et al., 2010; Utsugi et al., 1999; Utsugi et al., 1995; Yoh et al., 2007). 
Testing this model will require monitoring changes in Yra1 ubiquitylation and 
defects in mRNA export upon deletion of the Spt6 binding region on Tom1.  
 Spt6 may also function with Tom1 in other processes such as 
transcriptional regulation, degradation of excess histones, and cell cycle 
regulation. Potential substrates for Tom1 that may be important for these 
processes include Spt7, histones, and Dia2, respectively. Monitoring 
ubiquitylation and turnover of these proteins when the Spt6-Tom1 interaction is 
impaired may provide insight into the functional role of binding. If a targeted 
approach does not provide clues pointing to a biological process, unbiased 
strategies may be necessary. These could include RNA-Seq to identify targets of 
Tom1 in transcriptional regulation, pull-downs and proteomics to identify binding 
partners, and ubiquitin-activated interaction traps (O'Connor et al., 2015) to 
identify potential Tom1 substrates.  
 In order to gain structural insight into the mechanism of Tom1, we 
determined its structure using single particle cryo-EM. Consistent with the 
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observation that Tom1 is resistant to proteolysis, the structure reveals that the 
majority of Tom1, excluding the HECT domain and an acidic region, are 
substantially folded. The bulk of the structure is comprised of helical repeats, 
which was somewhat expected because two of the DUFs belong to a superfamily 
of helical repeat proteins. At this point, it is unclear what the purpose of this 
unusual fold is, but conservation of the overall domain architecture and large size 
suggests a functional importance. The most attractive model is that the lock 
washer region is a binding platform that recruits Tom1 to different substrates. 
The focus of future work should be to determine a higher resolution structure of 
Tom1 and structures of co-complexes with binding partners including Spt6. 
These structures will be particularly insightful in light of connections between 
Huwe1 and human disease. The work presented here provides the foundation for 
pursuing additional structures. 
 These results reveal an unexpected phosphorylation dependent 
interaction between Spt6 and Tom1. This interaction may be the missing link that 
connects Spt6 to mRNA export, or it could be involved in other processes such 
as transcriptional regulation, histone degradation, and cell cycle regulation. 
Alternatively, Spt6 binding to Tom1 could be important for an unanticipated 
aspect of biology. Overall, this work provides a foundation to address these 








Materials and Methods 
 
Plasmids and Yeast Strains 
 Plasmid pMS1 expresses Spt61223-1451 with an N-terminal SF-TAP tag 
(Gloeckner et al., 2007) and a C-terminal SV40 nuclear localization signal under 
control of the GAL1 promoter. The coding sequence for Spt61223-1451 was PCR 
amplified from genomic DNA with a forward primer that introduced the sequence 
coding for the FLAG epitope. The PCR product was digested with NdeI and 
BamHI and ligated into pTF198 (Yep_LEU2_Gal1; Tim Formosa) to create 
pTF254. KpnI and XhoI sites were introduced between the FLAG epitope and the 
Spt6 tSH2 coding sequence using site-directed mutagenesis to create pTF254-
KpnI-XhoI. Primers encoding a Twin-Strep-tag (IBA) flanked by KpnI and XhoI 
sites were annealed and ligated into digested pTF254-KpnI-XhoI to create pMS1. 
Other plasmids are described in Chapter 3.  
 Yeast strains 9750 and 9844 were constructed in the laboratory of Tim 
Formosa. Both strains express Tom1 with a C-terminal PreScission Protease site 
followed by a Protein A tag. Strain 9750 expresses full-length Tom1 whereas 
strain 9844 expresses Tom1 with residues 1921-1947 deleted. For both strains, 
the endogenous Tom1 promoter was replaced with the GAL1-GAL10 promoter in 
S. cerevisiae, allowing overexpression by addition of galactose to the media.  
 
Tandem Affinity Purification 
 
 Yeast transformed with plasmid pMS1 (SF-Spt61223-1451) or pTF198 
(empty) were cultured in 2 liters synthetic media containing glycerol and lactate in 
baffled flasks at 30°C. When the OD600 reached ~1, expression was induced by 
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the addition of galactose to 0.55% and the culture grown overnight. Cells were 
harvested by centrifugation and lysed under liquid nitrogen using a freezer mill. 
Subsequent steps were performed at 4°C. Yeast powder was suspended in an 
equal volume of lysis buffer (100 mM Tris pH 7.5, 300 mM NaCl, 10% glycerol, 1 
mM DTT, 0.1% Tween-20, 1x protease inhibitors [0.5 µg/ml aprotinin, 0.5 µg/ml 
leupeptin, 0.7 µg/ml pepstatin, 167 µg/ml PMSF], 1x phosphatase inhibitors [2 
mM NaVO4, 2 mM BGP, 2 mM NaF], 6 µg/ml DNAse, 2 µg/ml RNAse A) and 
clarified by centrifugation at 27,000 RCF for 30 minutes. 120 µg avidin was 
added to the clarified lysate and incubated for 15 minutes to block biotinylated 
proteins. Lysates were clarified further by ultracentrifugation at 107,000 RCF for 
1 hour. The supernatant was applied to 100 µl Strep-Tactin® Superflow resin 
(IBA) and incubated for 1 hour. The resin was washed with 10 column volumes of 
wash buffer (50 mM Tris pH 7.5, 150 mM NaCl, 5% glycerol, 0.1% Tween-20, 1x 
protease and phosphatase inhibitors, 6 µg/ml DNAse, 2 µg/ml RNAse A) and 
eluted with buffer containing 2 mM desthiobiotin. The eluate was applied to 50 µl 
anti-FLAG® M2 affinity gel (Sigma-Aldrich) and incubated for 1 hour. The resin 
was washed 3 times with 100 µl wash buffer and eluted with 150 µl wash buffer 
containing 200 µg/ml FLAG peptide. Proteins were separated by SDS-PAGE on 
NuPAGE™ Novex™ 4-12% Bis-Tris Protein Gels (Invitrogen) in MOPS running 
buffer, and proteins were visualized by coomassie staining.  
 
Protein Expression and Purification 
 
 Spt6 proteins were purified as described in Chapter 3. 
 Tom1 was purified from yeast strains 9750 and 9844. Cultures that were 
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grown to saturation were used to inoculate 2 L of YP containing glycerol and 
lactate to an OD600 of 0.2. Yeast were grown at 30°C in baffled flasks on an 
orbital shaker. Expression was induced by the addition of galactose to ~0.5% 
when the OD600 reached ~1, and cultures were grown overnight. Cells were 
harvested by centrifugation and lysed under liquid nitrogen using a freezer mill. 
Subsequent steps were performed at 4°C. Yeast powder was suspended in 2 
pellet volumes of suspension buffer (50 mM Tris pH 7.5, 500 mM NaCl, 10% 
glycerol, 1 mM DTT, 0.1% Tween-20, 1x protease inhibitors) and clarified by 
centrifugation at 37,000 RCF for 30 minutes. Clarified lysate was incubated with 
4 ml IgG Sepharose 6 Fast Flow resin (GE Healthcare) for 1 hour. Resin was 
washed 5 times with 8 ml of suspension buffer and 5 times with 4 ml IgG wash 
buffer (50 mM Tris pH 7.5, 150 mM NaCl, 5% glycerol, 1 mM DTT, 1x protease 
inhibitors). Tom1 was eluted by adding 4 ml IgG wash buffer containing 24 µg/ml 
PreScission Protease and incubating overnight. The resin was washed with an 
additional 8 ml IgG wash buffer that was pooled with the elution. The IgG elution 
was applied to a 5 ml HiTrap Q column (GE Healthcare) and eluted with a NaCl 
gradient. Tom1 eluted at ~500 mM NaCl. Fractions containing Tom1 were 
pooled, concentrated, and loaded onto a Superdex 200 size exclusion column 
(GE Healthcare) equilibrated in sizing buffer (15 mM Tris pH 7.5, 100 mM NaCl, 
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Far Western Blots 
 
 Far western blots were performed as described previously  (Wu et al., 
2007) and in Chapter 3. Either 20 µl FLAG elution or 1.1 pmol purified Tom1 
were loaded into each lane of a NuPAGE™ Novex™ 4-12% Bis-Tris Protein Gel 
(Invitrogen) and run in MOPS buffer. For CIP treated Tom1, purified Tom1 was 
diluted to 300 nM in phosphatase buffer (50 mM Tris pH 7.5, 100 mM NaCl, 10 
mM MgCl2, 5% glycerol, 0.1% Tween-20, 1 mM DTT, 1x protease inhibitors) and 
incubated with 0.3 U/µl CIP (New England BioLabs) for 1 hour at room 




 100 µg of purified Tom1 was incubated with 100 ng trypsin in 200 µl sizing 
buffer at room temperature. Time points were collected at 30 seconds, 1 minute, 
3 minutes, 10 minutes, 20 minutes, and 30 minutes. Reactions were quenched 
by the addition of aprotinin, leupeptin, PMSF, and SDS-loading dye followed by 
boiling for 3 minutes. Time points were resolved by SDS-PAGE on NuPAGE™ 
Novex™ 4-12% Bis-Tris Protein Gels (Invitrogen) in MOPS running buffer, and 
proteins were visualized by coomassie staining or transferred to a membrane for 




 Fluorescence anisotropy assays were performed as described in Chapter 





 3 µl of purified Tom1 at 2.5 µM was applied to glow discharged Quantifoil 
R2/2 holey carbon grids and incubated for 30 seconds at 4°C and 80% humidity. 
Grids were blotted for 8 seconds and plunge frozen in liquid ethane using a 
Vitrobot (FEI). Data were collected on a TF20 (FEI) microscope operating at 
200kV equipped with a K2 Summit direct electron detector (Gatan).  
 CTF parameters were estimated using CTFFIND4 (Rohou and Grigorieff, 
2015). Initial 2D class averages were calculated from ~9,000 particles that were 
picked semi-automatically using the swarm tool in e2boxer.py (EMAN2) (Tang et 
al., 2007). Eight distinct 2D class averages were low pass filtered to 20 Å and 
used as templates for autopicking in RELION (Scheres, 2015). The resulting 
particles were filtered in multiple rounds of 2D class averaging. A consensus 3D 
reconstruction was computed and refined in RELION (Scheres, 2012) using a 
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MECHANISM OF SPT6 HISTONE CHAPERONE 
 





 Spt6 is a histone chaperone that binds and reassembles nucleosomes in 
the wake of elongating RNAPII. This activity is essential to restore the default 
repressive chromatin state and to prevent inappropriate transcription initiation. 
Nucleosome binding by Spt6 requires a region of the protein that overlaps with 
the Spn1-binding site, and Spn1 competes with nucleosomes for Spt6 binding in 
vitro. In an effort to understand the molecular details of the histone chaperone 
activity of Spt6, we have performed direct binding and competition assays. These 
data reveal that Spt6 binds the globular core of histone H3-H4 tetramers [(H3-
H4)2] and competes with DNA for binding. Further, we provide evidence that the 
Spn1-Spt6 and Spt6-(H3-H4)2 interactions are mutually exclusive. Mutations that 
specifically disrupt the interaction with (H3-H4)2 in vitro cause synthetic growth 
defects in vivo when combined with mutations in Spn1 or other histone 
chaperones. Overall, the data presented here support the model that Spn1 plays 
a regulatory role in the histone chaperone activity of Spt6, and imply a 






 Eukaryotic organisms use an efficient packaging system known as 
chromatin to compact large genomes into the nucleus of each cell (Li and 
Reinberg, 2011). However, much of the DNA needs to be accessed on a regular 
basis, which requires that chromatin compaction to be dynamic. For example, 
transcription by RNA polymerases requires accessing, processing, and 
repackaging relevant segments of the genome. Therefore, chromatin dynamics 
are intimately linked to biological function and are highly regulated.  
 The fundamental packaging unit of chromatin is the nucleosome, which 
consists of two copies of each of the core histone proteins H2A, H2B, H3, and H4 
that are wrapped 1.7 times by ~147 base pairs of DNA (Luger et al., 1997). 
Nucleosomes create a physical barrier to DNA templated processes such as 
transcription by RNAPII (Lorch et al., 1992). Consequently, different classes of 
proteins and protein complexes mediate access to DNA by altering nucleosome 
position and occupancy. Histone chaperones bind the highly charged surfaces of 
histones to prevent aberrant interactions and promote assembly or disassembly 
of nucleosomes (Gurard-Levin et al., 2014; Park and Luger, 2008; Ransom et al., 
2010). Spt6 is a highly conserved, essential histone chaperone that is involved in 
several facets of gene expression including transcription, mRNA processing and 
export, histone posttranslational modification, and nucleosome positioning 
(Ardehali et al., 2009; Bucheli and Buratowski, 2005; Clark-Adams and Winston, 
1987; Compagnone-Post and Osley, 1996; DeGennaro et al., 2013; Dronamraju 
and Strahl, 2014; Endoh et al., 2004; Hartzog et al., 1998; Ivanovska et al., 2011; 
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Kaplan et al., 2005; Perales et al., 2013; Yoh et al., 2007; Yoh et al., 2008). 
 The most well-characterized role of Spt6 is to reassemble nucleosomes in 
the wake of RNAPII in order to re-establish a repressive chromatin state that 
prevents initiation from cryptic promoters (Kaplan et al., 2003). Spt6 coordinates 
nucleosome reassembly with transcription by directly binding RNAPII (Yoh et al., 
2007). Other Spt6 activities that contribute to nucleosome reassembly include 
direct binding to histones (Bortvin and Winston, 1996; McCullough et al., 2015), 
nucleosomes (McDonald et al., 2010), and DNA (Close et al., 2011).  
 The Saccharomyces cerevisiae Spt6 protein is large (~168 kDa) and has 
at least three distinct structural regions (Close et al., 2011). The disordered N-
terminal region is ~300 residues and highly acidic. The Spt6 core contains five 
recognizable domains and is structurally similar to the bacterial Tex protein 
(Johnson et al., 2008). The C-terminal region of Spt6 contains a tandem SH2 
domain comprising the only identified SH2 domains in yeast (Close et al., 2011; 
Diebold et al., 2010b; Sun et al., 2010). The N-terminal region of Spt6 is critical 
for Spt6 function and is necessary for binding nucleosomes (McDonald et al., 
2010). Interestingly, a 30 residue segment in this region also binds the 
transcription factor Spn1 in a manner that is competitive with nucleosomes, 
suggesting a potential regulatory switch (McDonald et al., 2010). Consistent with 
this, mutating the Spt6-Spn1 interface causes defects in maintaining repressive 
chromatin that can be suppressed by H2A-H2B mutations as well as 
overexpression of Spn1 (McCullough et al., 2015). The Spt6 interaction with 
nucleosomes requires the presence of the small HMGB family member Nhp6 that 
  
131 
is thought to bind DNA and weaken the histone-DNA contacts (Stillman, 2010). 
This suggests that the histone chaperone activity of Spt6 may involve competing 
with DNA for histone binding as has been observed for other chaperones 
(Andrews et al., 2010; Kemble et al., 2015; Winkler et al., 2011). In order to gain 
insight into the molecular details of the histone chaperone activity of Spt6, and to 
assess the potential regulatory role of Spn1 in this process, we utilized 
biochemical binding and competition assays. The data presented here suggest 
that Spt6 has multiple (H3-H4)2 binding sites, one of which resides in the Spn1 
binding region. The Spt6-(H3-H4)2 interaction is competitive with both Spn1 and 
DNA. Mutations that specifically disrupt the interaction with (H3-H4)2 cause 
synthetics defects in combination with mutations in Spn1 and other histones 
chaperones in vivo, confirming the biological importance of the interaction. 
Overall, these data support the model that Spn1 regulates the histone chaperone 
activity of Spt6, and demonstrate that Spt6 utilizes a DNA-competition 




Mapping the Spt6-(H3-H4)2 Binding Interface 
 
 Spt6 has been reported to bind H3-H4 (Bortvin and Winston, 1996; 
McCullough et al., 2015). In order to investigate this interaction more 
quantitatively, we used fluorescence anisotropy to measure binding affinities of 
different Spt6 constructs to H3-H4 derived from Xenopis lavis. For larger Spt6 
constructs, Spt6 was titrated into fluorescently labeled histones (Figure 5.1A). 




Figure 5.1. The Spt6-Spn1 binding region is sufficient for binding histones 
H3-H4. 
A) Fluorescence anisotropy binding assay with different Spt6 constructs titrated 
against fluorescently labeled H3-H4. 
B). Fluorescence anisotropy binding assay with H3-H4 titrated against 
fluorescently labeled Spt6239-268. 




5.1B). All constructs containing the Spn1 binding region (residues 239-268) 
bound (H3-H4)2 with an equilibrium dissociation constant (KD) between 1 and 4 
µM, indicating that these residues are sufficient for binding (Figure 5.1C). 
Surprisingly, removing these residues did not affect binding, suggesting that an 
additional independent binding site exists. We focused on the binding site in the 
Spn1 binding region for this work.  
 
Characterizing the H3-H4 Interaction with Spt6 
 
 Because histones H3-H4 form a symmetric tetramer, there is a possibility 
for two identical binding sites that would allow two Spt6 molecules to bind one 
tetramer. Using isothermal titration calorimetry (ITC), the stoichiometry of Spt6239-
489 binding to (H3-H4)2 was found to be 1:1 Spt6:(H3-H4)2 (Figure 5.2A). The KD 
in this assay was ~2 µM, consistent with our anisotropy assays. There are two 
possible explanations for the observed stoichiometry: 1) the (H3-H4)2-Spt6 
binding site spans adjacent dimers or 2) two equivalent binding sites exist, but 
binding of one Spt6 molecule occludes the other binding site. In order to test 
these models, we used fluorescence anisotropy to measure the affinity of Spt6 
for dimeric H3-H4 that are unable to form tetramers because of a mutation in the 
H3-H3’ interface (Figure 5.2B and C). H3-H4 dimers bound Spt6 with an affinity 
similar to tetramers, indicating that the tetramer interface is not required for 
interaction with Spt6. These results support a model where binding of one Spt6 
to a H3-H4 tetramer occludes an equivalent binding site on the adjacent dimer. 
 Histones have disordered N-terminal tails that are subject to 




Figure 5.2. Spt6 binds globular H3-H4 with a 1:1 stoichiometry and is 
competitive with DNA. Seth McDonald performed the experiments shown in this 
figure. The slightly tighter affinities observed in this figure can be explained by 
person-to-person variation.  
A) ITC with Spt6239-489 and (H3-H4)2. Raw data are shown in the top panel and 
the binding isotherm in the bottom panel. Thermodynamic parameters and 
stoichiometry are shown. 
B) Fluorescence anisotropy assay. Wild type (H3-H4)2 or dimeric H3H114D-H4 
were titrated against fluorescently labeled Spt6239-268. 
C) Fluorescence anisotropy with Spt6239-1117 titrated against either wild type (H3-
H4)2 or tailless (H327-135-H420-102)2. 
D) Competition fluorescence anisotropy assay. Purified DNA was titrated against 
constant concentrations of Spt6239-268 (~1 nM) and (H3-H4)2 (5 µM). 
E) Schematic illustrating the competition fluorescence anisotropy assay 
described in D. 
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determine if the H3-H4 tails are necessary for binding with Spt6, we tested 
binding to H3-H4 lacking the N-terminal 26 and 19 residues respectively. The 
“tailless” histones bound labeled Spt6239-268 as well as full-length (H3-H4)2 (Figure 
5.2D), supporting an interaction with the globular region of H3-H4. 
 Histone chaperones Nap1 and FACT act by competing with DNA for 
histone binding (Andrews et al., 2010; Kemble et al., 2015; Winkler et al., 2011). 
The requirement of Nhp6 for Spt6 binding to nucleosomes suggests that Spt6 
uses a similar mechanism. We used a competition fluorescence anisotropy assay 
to directly determine if DNA competes with Spt6 for binding (H3-H4)2. Labeled 
Spt6239-268 and (H3-H4)2 were kept at constant concentrations while the 
concentration of double stranded 147 bp “601” DNA was varied. DNA efficiently 
competed with Spt6 for (H3-H4)2 binding with an IC50 of 0.71 µM (Figure 5.2E). 
This suggests a model where Spt6 promotes nucleosome assembly by blocking 
nonproductive interactions between (H3-H4)2 and DNA.   
 
Spt6 Interaction with H3-H4 is Competitive with Spn1 
 
 It has been demonstrated that Spn1 prevents Spt6 interaction with 
nucleosomes (McDonald et al., 2010). Because Spn1 and H3-H4 bind the same 
region on Spt6, it is likely that Spn1 competes with H3-H4 for binding. We used a 
competitive fluorescence anisotropy assay to test this hypothesis. Fluorescently 
labeled H3-H4 and Spt6239-1117 were kept at constant concentrations while the 
concentration of Spn1 was varied.  Consistent with our hypothesis, Spn1 
competed with H3-H4 for Spt6 binding (Figure 5.3A).  Unfortunately, a full 




Figure 5.3. Spn1 competes with (H3-H4)2 for binding to Spt6. 
A) Competition fluorescence anisotropy assay. Spn1148-239 was titrated against 
constant concentrations of fluorescently labeled H3-H4 (1 nM) and Spt6239-1117 (5 
µM). 
B) Spn1 has weak affinity for H3-H4 in a fluorescence anisotropy binding assay. 
Spn1148-239 was titrated against fluorescently labeled H3-H4.  
C) GST pull-down assays with GST-Spn1148-307, Spt6236-1259, and (H3-H4)2. H3-
H4 does not pull-down in a ternary complex with Spn1 and Spt6, even though 
H3-H4 binds Spt6 under the same conditions (data not shown). Seth McDonald 
performed this experiment. 
  
137 
 concentrations above 10 µM (Figure 5.3B). Competition between Spn1 and H3-
H4 is further supported by the absence of a ternary complex in GST pull-downs 
under conditions that Spt6 is capable of interacting with both Spn1 and H3-H4 
(Figure 3C). These data support a model where Spn1 regulates the histone 
chaperone activity of Spt6. 
 
Mutations Disrupt the Spt6-(H3-H4)2 Interaction In Vitro 
 
 In order to demonstrate specificity and develop tools to test our model in 
vivo, we identified Spt6 mutations that disrupt binding to H3-H4 in vitro. Scanning 
mutagenesis of the Spt6-Spn1 binding region was used to identify mutations that 
disrupt binding in a competition fluorescence anisotropy assay. Purified 
recombinant Spt6239-268 proteins were titrated into constant concentrations of 
H3H114D-H4 and fluorescently labeled Spt6239-268. The Spt6MYD245KKR triple mutant 
reduced binding ~60 fold compared to wild type, demonstrating that the 
interaction is specific (Figure 5.4A). A single mutation of Spt6Y246K reduced 
binding ~6 fold compared to wild type. Importantly, this mutation did not affect 
binding to Spn1 (Figure 5.4B). We also tested the Spt6F249K mutation that is 
known to disrupt the interaction with Spn1 for binding to (H3-H4)2. This mutation 
had no effect on binding (Figure 5.4C). The ability to specifically disrupt the 
interactions with (H3-H4)2 and Spn1 independently allows for “separation of 






Figure 5.4. Mutations specifically disrupt the Spt6-(H3-H4)2 interaction in 
vitro. 
A) Competition fluorescence anisotropy assay. Spt6239-268 mutants were titrated 
against constant concentrations of fluorescently labeled Spt6239-268 and H3H114D-
H4. IC50’s are reported. 
B) Same as in A except Spt6 mutants were titrated against Spt6239-268 and 
Spn1148-239. IC50’s are reported. 
C) Fluorescence anisotropy assay in 200 mM NaCl. Spt6239-1117 wild type or 
F249K were titrated against fluorescently labeled H3-H4. KD’s are reported. Seth 
McDonald performed this experiment. 
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The Spt6-(H3-H4)2 Interaction Is Important In Vivo 
 
 To confirm that the Spt6 interaction with H3-H4 observed in vitro is 
physiologically important, we introduced the spt6-Y246K mutation into the 
genome of yeast such that the mutant protein was expressed from its native 
promoter. spt6-Y246K did not cause a phenotype on its own under the conditions 
tested (Figure 5.5A). Combining spt6-Y246K with pob3-Q308K, a mutation in the 
Pob3 subunit of the histone chaperone FACT, results in impaired growth at 
elevated temperatures and sensitivity to the replication toxin hydroxyurea (HU). 
Similar phenotypes are observed when spt6-Y246K is crossed with a deletion of 
the histone chaperone Hpc2 or spn1-F267E, a mutation that disrupts the 
interaction with Spt6. Collectively, these results indicate that the Spt6-(H3-H4)2 





 Spt6 was previously shown to bind histones H3-H4 and promote 
nucleosome deposition in vitro (Bortvin and Winston, 1996; Formosa, 2012). In 
order to better understand the mechanism of Spt6-mediated nucleosome 
assembly, we have begun characterizing the histone binding sites on Spt6. We 
used fluorescence anisotropy to demonstrate that the same 30 residue region of 
Spt6 that binds Spn1 also binds histones H3-H4. These interaction are mutually 
exclusive, but can be selectively disrupted by point mutations. Disrupting the 
Spt6-(H3-H4)2 interface in vivo causes growth defects when other modulators of 




Figure 5.5. The Spt6-(H3-H4)2 interaction is important in vivo.  
Spot plates of yeast harboring the spt6-Y246K mutation. These experiments 
were performed in the laboratory of Tim Formosa. 
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 (H3-H4)2 is a symmetric dimer of H3-H4, suggesting the possibility of two 
identical binding sites. However, Spt6 binds H3-H4 dimers and tetramers with 
equivalent affinity and tetramers with a 1:1 stoichiometry. These results suggest 
that two binding sites should exist, but binding of Spt6 to one H3-H4 site 
occludes the second binding site. This would require that the binding site be 
close to the tetramer interface. Binding is also competitive with DNA, consistent 
with the requirement of Nhp6 for Spt6 binding to nucleosomes (McDonald et al., 
2010). The most likely H3-H4 binding site that would allow for competition with 
DNA and be near the tetramer interface is adjacent to the nucleosome dyad. In 
support of this, the docking program ClusPro 2.0 (Comeau et al., 2004a, b) 
predicts a binding site in this region (data not shown).  
 Our mapping reveals that the Spt6-Spn1 binding region is sufficient but 
not necessary for binding H3-H4, suggesting the existence of an additional 
binding site. This binding site appears to be independent from the Spn1 binding 
region as there is little difference in affinity when the Spn1 binding region is 
removed. If the binding sites were coordinated, we would expect to see 
significantly tighter binding when both sites are present due to avidity effects. 
Consistent with the existence of other binding sites, a mutation that disrupts the 
Spt6239-268-(H3-H4)2 interaction does not have a phenotype unless combined with 
mutations in other proteins that modulate chromatin structure. On the other hand, 
mutations that impair the Spt6-Spn1 interaction cause severe growth phenotypes 
(McDonald et al., 2010).  
 Collectively, the work presented in this chapter expands our 
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understanding of how Spt6 chaperones histones. These results suggest a model 
where Spt6 promotes nucleosome assembly by preventing non-nucleosomal 
histone-DNA contacts. This appears to be accomplished through multiple 
independent binding sites, one of which overlaps with the Spn1 binding region. 
Additional biochemical studies are necessary to map the other binding site(s) and 
determine its contribution to nucleosome assembly. Spn1 may be actively 
engaged in chaperoning histones, possibly by disengaging Spt6 from 
nucleosomes in order to recycle it for subsequent rounds of reassembly. 
Alternatively, Spn1 may regulate Spt6 recruitment to sites of nucleosome 
reassembly. Regardless, Spt6 interactions with Spn1 and histones are important 
in vivo and additional studies are required to understand the mechanistic basis of 
nucleosome reassembly by Spt6. 
 
Materials and Methods 
 
Protein Expression and Purification 
 Spt6 and Spn1 proteins were expressed and purified as described 
previously (McDonald et al., 2010) with one modification: Spt6 constructs with C-
terminal truncations at or before residue 489 were purified via anion-exchange 
chromatography (5 mL Q HP, GE Healthcare) in place of a Heparin cation-
exchange column.  
 Xenopus laevis histones were expressed recombinantly and purified from 
inclusion-bodies as described elsewhere (Luger et al., 1999). ‘Tailless’ histones 
were prepared by inserting a PreScission Protease site such that upon protease 
treatment (after refolding), a GP dipeptide remains N-terminally fused to the 
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following residues: H327-135 and H420-102. Mutating H3 H114, a residue in the H3-
H3 tetramerization interface, to an aspartate produced dimeric histones (Andrews 
et al., 2008). Fluorescent labeling of histone H4T71C and Spt6239-268 with Oregon 
Green-488 maleimide (Invitrogen) was performed according to manufacturers 
instructions. Spt6239-268 was labeled on a cysteine residue introduced by site-





 The 147 bp “601” nucleosome positioning sequence fragment was purified 
from large-scale DNA plasmid preps of pST55 (a gift from Song Tan), followed by 




 All fluorescence anisotropy assays were incubated for 1 hour and 
measured at 25°C in 384-well flat bottom black (nonbinding surface) microplates 
(Corning).  Purified Spt6 proteins were titrated in 1.6-1.8 fold serial dilutions 
against a constant concentration (0.5-1 nM) of labeled histones in anisotropy 
buffer (20 mM Tris pH 7.5, 750 mM NaCl, 5% glycerol, and 1 mM DTT). For Spt6 
F249K, assays were performed in low salt anisotropy buffer with 200 mM NaCl. 
KD values were determined by fitting the data in GraphPad Prism® using 
nonlinear least squared regression against A = AT / (2 × [pep]) × (([pro] + [pep] + 
KD) – (([pro] + [pep] + KD)
2 – 4 × [pro] × [pep])1/2) (LiCata and Wowor, 2008), 
where A is the measured anisotropy, AT is the total change in anisotropy, [pep] is 
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the peptide concentration, and [pro] is the protein concentration. DNA 
competition assays were performed in anisotropy buffer by titration of DNA 
against a constant concentration of labeled Spt6238-269 (1 nM) and H3-H4 (5 µM). 
Competition assays with Spt6 mutants were performed in anisotropy buffer by 
titration of Spt6 proteins against constant concentrations of labeled Spt6239-268 (1 
nM) and H3H114D-H4 (5 µM). IC50 values were determined by fitting to the 
standard IC50 equation in GraphPad Prism®.  
 
Isothermal Titration Calorimetry 
 
 Purified recombinant proteins were dialyzed at 4°C overnight against 2 L 
of degassed ITC buffer (20 mM HEPES pH 7.5, 750 mM NaCl, 0.5 mM EDTA, 5 
% glycerol, and 1 mM DTT). Titrations were done at 25°C on an iTC200 
(Microcal) and spaced 180 s apart. Spt6239-489 was tested with 1.8 µL injections of 
1.25 mM Spt6 into 0.125 mM (H3-H4)2. Origin software (Microcal) was used for 
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 Spt6 is conserved throughout eukaryotes, is homologous to the 
prokaryotic transcription factor Tex, and is essential in S. cerevisiae. Spt6 
influences several facets of gene expression including transcription, mRNA 
processing and export, posttranslational modification of histones, and 
nucleosome occupancy. The mechanistic details of Spt6 involvement in these 
processes are unknown, but interactions with proteins and nucleic acid are likely 
important. The focus of this dissertation has been to identify and characterize 
Spt6 binding partners. Chapter 2 reported a crystal structure of Spt6 including a 
C-terminal tandem SH2 domain. The tSH2 structure and accompanying 
biochemistry formed the basis for the work in Chapters 3 and 4.  
 In Chapter 3, I showed that, contrary to popular belief, Spt6 tSH2 binds 
the phosphorylated Rpb1 linker but not the CTD. The interaction is 
phosphorylation dependent and biologically important for maintaining repressive 
chromatin. The work in Chapter 4 identified phosphorylated Tom1 as a previously 
unidentified Spt6 tSH2 binding partner that may connect Spt6 to mRNA export. In 
addition, an 8 Å cryo-EM reconstruction revealed that ~300 kDa of the 375 kDa 
Tom1 protein are substantially folded, forming the basis for a mechanistic 
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understanding of Tom1.  
 In Chapter 5, in collaboration with Seth McDonald, I characterized the 
interaction between histones H3-H4 and the Spt6-Spn1 binding region. Those 
studies support a model in which Spt6 competes with DNA for H3-H4 binding to 
prevent non-nucleosomal DNA-histone interactions. This chapter describes 
ongoing studies of Spt6 and Tom1 and discusses additional experiments 
designed to further understand the diverse roles of these multifaceted proteins.  
 
Function of the Spt6 Core 
 
 The core of Spt6 is structurally similar to the prokaryotic transcription 
factor Tex (Johnson et al., 2008) and contains five domains with structural 
homology to protein-binding and nucleic acid-binding domains (Close et al., 
2011). Therefore, it is likely that the Spt6 core participates in direct binding 
interactions with other proteins and/or nucleic acids. Consistent with this, Spt6 
binds DNA in vitro, although it is unclear if this is biologically relevant (Close et 
al., 2011). At this point, no proteins have been identified that bind specifically with 
the Spt6 core, although I believe that interacting proteins are likely to be 
fundamental to Spt6 function. Therefore, their identification will be a key step in 
advancing understanding of Spt6 functions and mechanisms. In order to identify 
Spt6 core binding partners, a proteomics approach similar to that utilized for the 
tSH2 domain (Chapter 4) should be pursued. The Spt6 core can be 
overexpressed in yeast with tandem affinity tags and purified under physiological 
conditions to identify co-purifying species. Identifying and characterizing these 
binding interactions is expected to shed light on how Spt6 participates in such a 
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wide variety of biological processes. 
 
Spt6 tSH2 Phosphotyrosine Binding 
 
 The work presented in Chapter 3 identifies a biologically relevant 
interaction between Spt6 tSH2 and the Rpb1 linker. Preliminary evidence 
suggests that an additional phosphorylation dependent interaction with the Rpb1 
linker is mediated by the putative phosphotyrosine binding pocket. In our crystal 
structure, the N-terminal residues of the linker are approaching the highly 
conserved phosphotyrosine binding pocket of the canonical nSH2 domain. 
Modeling additional Rpb1 residues into our crystal structure reveal that a 
conserved tyrosine (Rpb1 Y1473) would be in good position to sit in the 
phosphotyrosine binding pocket (Figure 6.1A). In support of this, phosphorylation 
of this tyrosine has been observed in high throughput mass spectrometry 
experiments (Albuquerque et al., 2008). Another residue (Rpb1 T1471) two 
amino acids N-terminal to Y1473 is also strictly conserved, has also been 
observed to be phosphorylated by mass spectrometry (Albuquerque et al., 2008), 
and is marginally important for Spt6 tSH2 binding in a far western blot (Chapter 
3). In support of Rpb1 Y1473 and T1471 contributing to Spt6 binding, mutation of 
either residue in yeast has strong synthetic defects with rpb1-S1493A and Spt6 
mutations in the phosphoserine binding pocket (data not shown). The same 
synthetic defect is seen when a mutation in the putative Spt6 phosphotryosine 
binding pocket (spt6-R1282H) is combined with mutations that impair 
phosphoserine binding. The growth defect observed when both Spt6 tSH2 




Figure 6.1. Phosphorylation of Rpb1 Y1473 may contribute to Spt6 tSH2 
binding through the canonical phosphotyrosine binding pocket. 
A) Model of Rpb1 pY1473 docked into the Spt6 tSH2 phosphotyrosine binding 
pocket. Spt6 tSH2 is colored according to electrostatic surface potential. The 
putative phosphotyrosine binding pocket is highlighted with an orange dashed 
circle. Rpb1 is shown as yellow sticks. The Spt6 tSH2-Rpb1 linker structure was 
modified by modeling additional residues at the linker N-terminus. Modeling was 
performed in COOT (Emsley et al., 2010) and the figure was generated using 
UCSF Chimera (Pettersen et al., 2004). 
B) Alignment of a portion of the Rpb1 linker across eukaryotes. The presence of 
a tyrosine (S. cerevisiae 1473, black arrowhead) 18-20 residues N-terminal to 
S1493 is strictly conserved. Sequences were aligned using T-Coffee (Notredame 
et al., 2000) and displayed using ESPript (Robert and Gouet, 2014). White 
characters on a red background represent invariant residues and red font on a 





complete deletion of the entire tSH2 domain. An attractive model to explain these 
observations is that the Spt6 tSH2-Rpb1 linker interface extends beyond the 
surface characterized in Chapter 3 and likely involves additional phosphorylation 
events. Linker derived peptides with different combinations of phosphorylation 
marks are being synthesized to test for binding. Tightly binding peptides will be 
further characterized by x-ray crystallography. In addition, ChIP studies are 
underway to determine the impact of mutating the Spt6 phosphate binding 
pockets on Spt6 recruitment to genes.  
 
Spt6 Interaction with the RNAPII Core 
 
 Spt6 displays a relatively rare ability to stimulate RNAPII elongation rates 
in vitro on nucleosome free DNA (Endoh et al., 2004). It is difficult to imagine how 
Spt6 binding to the flexible Rpb1 linker could be responsible for this activity. It is 
possible that Spt6 tSH2 binding to the linker destabilizes association of Rpb4/7 
with the core to enhance elongation. This seems unlikely, as it has never been 
demonstrated that the linker contacts with Rpb4/7 observed in the S. pombe 
crystal structure are functionally important. Another possibility is that Spt6 
interacts directly with the RNAPII core in order to facilitate more efficient 
transcription elongation. Consistent with this, preliminary pull-down experiments 
suggest that Spt6 tSH2 binds the RNAPII core because substantial residual 
copurification is apparent when the Rpb1 CTD and linker are absent  (Figure 
6.2A and B). There are two possible explanations why this interaction was not 
observed in the far western blots described in Chapter 3. The first possibility is 




Figure 6.2. Spt6 tSH2 interacts with the RNAPII core in pull-down 
experiments. 
A) GST pull-downs using purified proteins. Wild type and truncated versions of 
purified RNAPII were passed over GST-Spt61223-1451 immobilized on glutathione 
resin. Bound proteins were resolved by SDS-PAGE and stained with coomassie. 
B) Tandem affinity purification of strep-FLAG tagged Spt61223-1451 (SF-tSH2) that 
was overexpressed in yeast strains with PreScission Protease sites inserted at 
different locations in Rpb1. The Rpb1 CTD and linker-CTD were cleaved off 
(ΔCTD, orange arrow; and Δlinker, cyan arrow) by incubation with PreScission 
Protease during the first purification step. Co-purifying proteins were resolved by 
SDS-PAGE and stained with coomassie. 
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the pull-down experiment, so that weaker interactions would not be detected by 
far western blot. The second explanation is that the interaction requires a 
structured RNAPII interface that is not refolded in the far western blot. 
Regardless, pull-downs using folded proteins suggest that a binding site exists 
for Spt6 on the RNAPII core, and this may explain how Spt6 stimulates 
transcription elongation.  
 We have attempted to visualize this interaction using cryo-EM, but were 
unable to identify density corresponding to Spt6 tSH2. We were not limited by 
resolution, as the average resolution of the reconstruction was 4.2 Å. We 
observed significant structural heterogeneity of RNAPII in our reconstruction. In 
fact, over half of our particles separated into 2D class averages that appeared to 
contain only half of RNAPII. This suggests that exposure to the air-water 
interface in the moments prior to vitrification could be causing our particles to fall 
apart, even with crosslinking. Therefore, it is possible that we are unable to 
sufficiently resolve the heterogeneity to be able to identify a group of 
homogenous particles that contain Spt6 tSH2 bound to the core. Alternatively, 
Spt6 tSH2 could be interacting with a flexible loop on the RNAPII core, so it is not 
well resolved. An additional possibility is that the interaction observed in pull-
downs is nonspecific. Even if the Spt6 tSH2 interaction with the core is 
nonspecific, other parts of Spt6 could be binding the RNAPII core. This is 
supported by the observation that deletion of Spt6 tSH2 domain diminishes, but 
does not eliminate Spt6 recruitment to genes (Burugula et al., 2014; Mayer et al., 
2010). In addition, the core of Spt6 is homologous the prokaryotic factor Tex 
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which co-purifies with bacterial RNA Polymerase (Simon Dove, unpublished 
data). Spt6 also shares overlapping domains with the mitochondrial transcription 
factor TEFM that directly binds the mitochondrial RNA Polymerase (POLRMT) 
(Minczuk et al., 2011; Posse et al., 2015). Because the Spt6 core may contribute 
to RNAPII binding, future attempts at cryo-EM should use a larger version of 
Spt6 that encompasses the core and tSH2 domain. In addition, including a 
nucleic acid template is advisable to more closely mimic a transcribing RNAPII 
complex. Finally, using grids with a thin layer of carbon could reduce the number 
of half particles by pulling particles away from the air-water interface prior to 
vitrification. 
 
Biochemical and Structural Characterization of Tom1 
 
 The identification of Tom1 as an Spt6 tSH2 binding partner (Chapter 4) 
was unanticipated, but the interaction appears to be biologically important. While 
the specific process the interaction is important for is unclear, Tom1 does have 
several activities that overlap with Spt6 including mRNA export, excess histone 
degradation, and cell cycle regulation. Of these, mRNA export is the most 
attractive because of overlapping genetic and physical association with Yra1 
(Burckin et al., 2005; Estruch et al., 2009; Iglesias et al., 2010; Utsugi et al., 
1999; Yoh et al., 2007). The most obvious experiment to test for mRNA export 
defects is to use fluorescence in situ hybridization (FISH) to monitor mRNA 
localization when the Tom1-tSH2 binding region is deleted in yeast. Testing the 
importance of the interaction for histone degradation is challenging, because the 
pool of free histones is relatively small compared to total cellular histone levels 
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(0.6% H3) (McCullough et al., 2013). Our collaborator Tim Formosa has 
developed tools that will be useful for identifying changes in free histone levels 
when the Spt6-Tom1 interaction is impaired (McCullough et al., 2013; Xin et al., 
2009). In addition, flow cytometry could be used to look for defects in cell cycle 
progression when the binding site is mutated. It may also be insightful to identify 
the pathway that regulates Tom1 phosphorylation, starting with the kinase. The 
sequence surrounding Tom1 S1943 resembles a casein kinase II (CKII) site 
(Glover, 1998). Since CKII has been associated with Spt6 function (Krogan et al., 
2002), it should be the first candidate investigated. 
 In the event that a targeted approach does not reveal the biological 
importance of the Spt6-Tom1 interaction, a more global strategy will be required. 
Our collaborator, Mahesh Chandrasekharan, is currently initiating RNA-seq 
studies to identify genes that are regulated in a Tom1 dependent manner. Other 
avenues of exploration could include identification of Tom1 binding partners and 
substrates. Tom1 could be pulled out from yeast in physiologic buffer conditions 
followed by mass spectrometry to identify co-purifying species. In addition, 
identifying Tom1 substrates may offer insight into the pathways in which Tom1 
participates. A recently described technique called ubiquitin-activated interaction 
traps (UBAITs) enables covalent attachment of E3 ligases to substrates by fusing 
ubiquitin to the C-terminus of the E3 (O'Connor et al., 2015). When the E3 
ubiquitylates a substrate using the fused ubiquitin, an amide linkage is formed, 
enabling co-purification and subsequent identification by mass spectrometry. We 
are currently generating tools to use this method for Tom1.  
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Spt6 Interactions with Histones 
 
 The work presented in Chapter 5 focuses on characterization of the 
interaction between the Spt6-Spn1 binding domain and histones (H3-H4)2. Our 
binding data indicate that this is just one of multiple (H3-H4)2 binding sites on 
Spt6. Identifying and characterizing the other binding site(s) is necessary to 
develop a complete mechanistic understanding of how Spt6 functions as a 
histone chaperone. ITC is likely the best technique for more thorough mapping, 
as it has the advantage of giving information about stoichiometry as well as 
binding affinity. This information will be useful in trying to distinguish between 
multiple independent sites with equivalent KD. Once individual binding sites are 
mapped, structural studies can be pursued to determine where Spt6 binds 
histones and how these contacts may relate to nucleosome assembly. 
 The strategy outlined above should also be used to map Spt6 interactions 
with histones H2A-H2B. Spt6 is classically thought of as an H3-H4 chaperone 
(Bortvin and Winston, 1996), but it is also capable of binding H2A-H2B 
(McCullough et al., 2015). Preliminary ITC data from David Kemble suggests the 
presence of four H2A-H2B binding sites on Spt6, and data from Seth McDonald 
indicate that the Spn1 binding region may be one of them (data not shown). It is 
unclear why Spt6 has binding sites for more histones than are present in the 
nucleosome. Each binding site may be functionally important, or they may be 
artifacts of in vitro biochemistry performed with proteins that are prone to non-
specific interactions. Careful biochemical characterization of the individual 
binding sites is necessary to determine if these interactions are specific. 
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Subsequently, mutations that disrupt each interface can be integrated into yeast 




 The importance of Spt6 for a diverse set of biological processes makes it 
an exciting target for mechanistic studies. The work in this dissertation expands 
on the foundational work of several former members of the Hill lab: Sean 
Johnson, Devin Close, and Seth McDonald. The primary focus has been 
identification and characterization of Spt6 interactions with protein binding 
partners. Understanding the interactions that Spt6 participates in is fundamental 
to understanding how Spt6 is recruited to its different functional activities. The 
finding that Spt6 tSH2 binds RNAPII through the flexible linker rather than the 
CTD presents an important correction to the literature. The interaction is 
enhanced by previously unidentified phosphorylation of the linker and is 
important for maintaining repressive chromatin. We have also made the 
unexpected discovery that Spt6 tSH2 not only binds RNAPII but also Tom1. 
Determining the biological role of the interaction will advance understanding of 
Spt6 and Tom1 functions. Towards understanding Tom1 at a mechanistic level, 
we have solved a cryo-EM structure that reveals a substantially folded protein 
composed of helical repeats. Finally, biochemical characterization of the 
interaction between the Spt6-Spn1 binding region and histones H3-H4 reveals a 
role for competition with DNA in Spt6 mediated nucleosome assembly. Ongoing 
work includes structural, biochemical, and genetic studies to more thoroughly 
characterize Spt6 interactions with RNAPII, Tom1, and histones. Dissecting 
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these interactions will bring us closer to complete mechanistic understanding of 
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